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ABSTRACT 
Overall, signaling events in human sperm, together with the identity of many of the 
molecules stimulating them, remain very poorly characterised. A two-pronged approach 
involving characterisation of sperm receptors in a model-cell system, followed by single cell 
[Ca2+]i imaging of large numbers of capacitated human spermatozoa, was employed to start 
to unravel some of these possibilities. Data were compared to responsiveness of the best-
characterised physiological ligand of sperm – the steroid hormone progesterone. 
Proteomic data strongly indicates the presence of OR2AE1, an olfactory receptor, in mature 
human sperm. OR2AE1 was cloned into the mammalian expression vector pcDNA3 and 
expressed in HEK293 cells. Functional expression of OR2AE1 (5.6±1.1% of cells showing 
correct localisation of FLAG-tagged recombinant receptor at the plasma membrane level) 
was demonstrated. Despite this relatively low level of functional expression, this system still 
allowed identification of a potent volatile agonist for OR2AE1 – omega () – via an 
elimination-panel system used alongside [Ca2+]i imaging. Around 3% of cells in the 
heterologous system generated a response to the agonist, indicating correct functional 
expression.  
When sperm were exposed to 50 µM , [Ca2+]i imaging revealed a transient response which 
occurred in 30-40% of capacitated cells. 10 µM NNC 55-0396, an antagonist of the CatSper 
channels, inhibited around 80% of these responses. Similar inhibition levels were 
demonstrated by inhibitors of the cAMP pathway (100 µM SQ22536 and 25 µM cAMPS-Rp), 
but no substantial effect was observed by inhibition of PLC by 5 µM U73122. Chemotactic 
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assays indicated that 50 µM  had an optimal chemoattractive effect, with 500 µM  
significantly stimulating acrosome reaction. 
An unrelated family of chemicals, the boronic acids, were also examined for their ability to 
affect sperm motility, migration and [Ca2+]i dynamics. A significant effect on the number of 
sperm which migrated from semen when exposed to these chemicals was observed, with 
pathway inhibition distinctly indicating a bifurcating signal propagating mainly via IP3 but 
also involving the cAMP pathway. 
Manipulation of the signalling events described, with inherent modulation of sperm motility 
may underlie the ability to develop future novel therapy, including contraceptive and 
diagnostic treatment regimes for the human male.  
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1. INTRODUCTION 
1.1. Olfaction 
Smell, otherwise known as olfaction, is a deep-rooted sense shared by vertebrates and other 
animals and forms an essential part of the set of chemosensory tools that allows them to 
perceive the environment around them. Olfaction identifies essential cues important for the 
organisation of feeding, mating and social behaviours that are strongly linked to  learning 
and memory. Among higher eukaryotes, from flies through to mammals, there is a striking 
evolutionary convergence towards a conserved organisation of signaling pathways in 
olfactory systems (Hildebrand and Shepherd, 1997). 
For air breathing organisms such as humans, odorants must be sufficiently volatile to be 
detected by the nose. A large fraction of volatile chemicals have a discernible odour, placing 
the number of ‘smellable’ chemicals in the range of the thousands, if not millions 
(Mombaerts, 2004). These odorants are mostly organic compounds, usually low molecular 
mass aliphatic or aromatic molecules, with varied carbon backbones and diverse functional 
groups, including aldehydes, esters, ketones, alcohols, alkenes, carboxylic acids, amines, 
imines, thiols, halides, nitriles, sulphides and ethers (Firestein, 2001). Most of the time these 
chemicals are present in the environment at very low concentrations, and therefore 
processing these stimuli requires a very sensitive system backed up by a massive repertoire 
of receptors to match the chemical heterogeneity. 
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1.1.1. Mammalian olfactory system 
The mammalian nasal cavity can include several olfactory subsystems (Figure 1.1), each of 
which serving different distinct functions. Normally two systems are distinguished: the main 
olfactory epithelium (MOE), responsible for sorting through the immense array of odorous 
molecules providing information about the external environment (food, predators, prey and 
territory), and the vomeronasal organ (VNO), which processes species specific airborne 
olfactory signals known as pheromones, conveying information about location and 
reproductive availability.  
 
 
Figure 1.1 – Olfactory subsystems in vertebrates 
The vertebrate nasal cavity (left) can include several olfactory subsystems: the main olfactory epithelium (MOE), the 
Vomeronasal organ (VNO), the Grüneberg ganglion (GG), the septal organ (SO) and guanylate cyclase D-containing cells 
(GCDs) in the MOE. Axons of sensory neurons in the MOE and SO project to glomeruli of the main olfactory bulb (MOB), 
sensory cells of the GG and GCDs send their axons to the necklace glomeruli (NG) and sensory neurons on the VNO project 
to the accessory olfactory bulb (AOB). Olfactory sensory neurons (OSNs) in the MOE are bordered by supporting cells and 
constantly regenerated from basal cells. Each OSN projects one dendrite that ends in a dendritic knob. From each dendritic 
knob cilia extend into the nasal mucus. Adapted from Kaupp, 2010. 
 
The MOE covers a series of cartilaginous outcroppings in the posterior nasal cavity, called 
turbinates, comprising 6-10 million olfactory sensory neurons (OSNs) (Firestein, 2001). Each 
of these bipolar sensory cells extend an axon from the proximal pole of the cell into a region 
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of the forebrain known as the olfactory bulb, and a single dendrite to the surface of the 
tissue, that ends in a knob-like structure projecting numerous long and very fine cilia into the 
layer of mucus covering the tissue. These chemosensoric cilia include both receptor proteins 
and elements of the olfactory signal transduction machinery and provide an extensive 
receptive surface for the interaction of odours with the cell. 
The VNO, located at the base of the nasal cavity, is enclosed in a cartilaginous or bony 
structure and divided by the nasal septum. The vomeronasal epithelium is isolated from the 
airstream in the nasal cavity, and the system relies on a pumplike action mediated by the 
surrounding vascular system to deliver stimuli to the VNO (Keverne, 1999). Receptor 
neurons interact with pheromones through apical microvilli and their axons form nerves 
converging at the accessory olfactory bulb (AOB) (Keverne, 1999). 
 
1.1.2. The olfactory receptor 
Olfactory receptors (Figure 1.2) form part of the G-protein coupled receptor (GPCR) 
superfamily and are characteristically encoded by intronless genes, sharing amino acid 
motifs that distinguish them from other non-OR seven-transmembrane proteins (Glusman et 
al., 2001). Their seven-transmembrane topology consists of seven transmembrane α-helices 
interconnected by extra and intracellular loops. Additionally, there is an extracellular N-
terminal chain and an intracellular C-terminal chain (Buck and Axel, 1991; Pilpel and Lancet, 
1999).  
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Figure 1.2 – Olfactory receptors 
Diagram of the three-dimensional structure of the olfactory receptor, based on the structure of rhodopsin. Like all GPCRs, 
ORs couple to G proteins. Transmembrane domains III-V (in orange) display the highest residue variability and are thought 
to include the odorant binding pocket. 
 
 
The number of ORs present in different mammalian species varies considerably (Table 1).  
Table 1 – Olfactory receptor repertoire in complete mammalian genomes  
Organism Species 
Number of OR genes 
Intact Pseudogenes Total 
Human Homo sapiens 384 467 851 
Chimp Pan troglodytes 353 546 899 
Dog Canis familiaris 713 258 971 
Mouse Mus musculus 1,194 181 1,375 
Rat Rattus norvegicus 1,284 292 1,576 
Opossum Monodelphis domestica 899 617 1,516 
adapted from Zhang and Firestein, 2009 
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Humans have 851 olfactory receptor genes, but 55% of these are listed as pseudogenes. 
Numbers in chimps are similar to human, whereas mice have a larger gene pool (1,375 ORs) 
with a much lower rate of pseudogenisation (13%) (Aloni et al., 2006; Glusman et al., 2001), 
probably relating to an evolutionary reduction in the sense of smell. Surprisingly, this 
reduction in functional ORs in primates has been correlated with the acquisition of 
trichromatic vision, suggesting that, at least in primates, better vision might have caused a 
partial redundancy in olfaction (Gilad et al., 2004). 
 
1.1.3. Olfactory signal transduction pathway 
Binding of the odour molecule (ligand) to the olfactory receptor triggers a cascade of events 
that converts chemical energy into a neural signal, and this is a generally well understood 
and comprehensively characterised process in mammalian chemosensoric systems.  
As reviewed by (Kaupp, 2010), activation of most olfactory receptor neurons by binding of 
an odorant to a specific olfactory receptor (Figure 1.1 and Figure 1.3a) stimulates the rapid 
synthesis of cAMP by adenylyl cyclase III (ACIII) via a process mediated by the olfaction-
specific G protein α subunit (Golf). This rise in cAMP causes cyclic nucleotide-gated channels 
(CNGCs) to open, which increases intracellular calcium concentration [Ca2+]i. This increase in 
calcium levels triggers the opening of Ca2+-activated chloride channels (CaCCs), and because 
OSNs accumulate rather than export chloride ions, the opening of CaCCs leads to chloride 
efflux that further depolarises the cell. Recovery and adaptation of the odorant-induced 
response involves several Ca2+-dependant and Ca2+-independent pathways: OSNs display 
both short and long term adaptation to brief or sustained stimulation respectively, and both 
modes of adaptation appear to be controlled by changes in [Ca2+]i (Zufall and Leinders-Zufall, 
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2000) and response termination may occur at all stages of the OR signaling pathway (Figure 
1.3b).  
 
 
 
Figure 1.3 – Signal transduction in mammalian olfactory sensory neurons 
a. The odour-induced signal transduction pathway; b. Recovery and adaptation of the odorant-induced response; adapted 
from Kaupp, 2010 
 
Recognition of odorants by olfactory receptors is widely accepted to follow the “lock-and-
key” molecular interaction model, where receptors identify particular molecular shapes in 
odorant molecules (Axel, 2005). More than a decade ago, however, Luca Turin (Turin, 1996) 
has proposed an alternative mechanism describing how ORs could “read” odorants, where 
molecular vibrations of either the whole odorant molecule or particular functional groups, 
instead of their shape, would be the “signature” contributing for odour recognition. This 
GDP 
GTP 
GDP 
GTP 
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work suggested that olfaction, together with colour vision and hearing, is in fact a spectral 
sense. A recent study by the same group (Franco et al., 2011), using deuteration of odorant 
molecules, shows that Drosophila melanogaster flies can differentiate between the 
deuterated and non-deuterated isotopes, odorant molecules with the same conformation 
but different vibrational modes. This cannot be explained by the “lock-and-key” model, and 
although this subject still remains controversial, the vibrational model has been gaining 
momentum.  
 
1.1.4. Ectopic expression of ORs 
Although ORs are predominantly expressed in the olfactory epithelium, there is ample 
evidence of these receptors being transcribed in non-olfactory tissues in several mammalian 
species, mainly in testis and germ cells (Asai et al., 1996; Goto et al., 2001; Linardopoulou et 
al., 2001; Parmentier et al., 1992; Spehr et al., 2003; Vanderhaeghen et al., 1997a; 
Vanderhaeghen et al., 1997b; Volz et al., 2003) but also in erythroid cells (Feingold et al., 
1999), tongue (Durzynski et al., 2005; Gaudin et al., 2001), prostate (Xia et al., 2001; Xu et 
al., 2000) and other tissues (Conzelmann et al., 2000; Itakura et al., 2006; Otaki et al., 2004; 
Weber et al., 2002; Yuan et al., 2001). Interestingly, ORs have also been reported in canine 
sperm (Vanderhaeghen et al., 1993) and, through proteomic approaches, in human mature 
sperm (Baker et al., 2007; Lefievre et al., 2007; Spehr et al., 2004). Furthermore, one of 
these receptors, OR1D2, previously identified in the testis, has been described as mediating 
the chemotactic response elicited by bourgeonal in human sperm (Spehr et al., 2003). To 
date OR1D2, together with the recently characterised OR7A5 and OR4D1 (Veitinger et al., 
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2011) remain the only ORs ectopically expressed in human with both a known ligand and a 
potential physiological role. 
 
1.1.5. Heterologous expression of ORs 
Since Buck and Axels’ discovery almost 2 decades ago (Buck and Axel, 1991), ORs have been 
the focus of intense research interest. However, lack of adequate heterologous systems for 
expressing and assaying odorant responses (McClintock and Sammeta, 2003) has hampered 
significant advances in the field, with very few receptor-ligand relationships for mammalian 
ORs having so far been identified (Mombaerts, 2004). Transfected ORs exhibit low levels of 
plasma membrane expression (functional expression), due to endoplasmic reticulum (ER) 
retention, leading to subsequent degradation by the proteosome (Gimelbrant et al., 2001; Lu 
et al., 2003; McClintock et al., 1997). Several strategies have been tested to circumvent this 
deficiency: adding an N-terminal leading sequence from another GPCR led to success in 
characterizing a limited number of ORs (Kajiya et al., 2001; Krautwurst et al., 1998; Wetzel et 
al., 1999), but currently the scope is on providing these systems with the molecular 
machinery necessary for correct translocation of these receptors to the plasma membrane 
on the host cell, as they would normally do in OSNs. In line with this, RTP1S and RTP2, 
together with a receptor expression-enhancing protein REEP1 have been reported to play 
important roles in receptor protein translocation to the plasma membrane of HEK293T cells 
(Saito et al., 2004; Zhuang and Matsunami, 2007), thus significantly enhancing OR functional 
expression. The co-expression of these accessory proteins with the olfactory-specific G-
protein α subunit Golf and a putative guanine nucleotide exchange factor Ric8b (Von 
Dannecker et al., 2005; Von Dannecker et al., 2006), and combination with N-terminal 
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tagging of receptors has promised success in high throughput de-orphaning of mammalian 
ORs (Zhuang and Matsunami, 2007). Furthermore, a testis-enriched variant of the Hsc70 
heat shock protein family (Hsc70t) has also been reported to facilitate OR expression in 
HEK293 (Neuhaus et al., 2006) and more recently the type 3 muscarinic acetylcholine 
receptor (M3-R), another GPCR found in mammalian OSNs, has been shown to interact with 
and enhance the responses to cognate odorants of several ORs expressed in HEK293T cells 
(Li and Matsunami, 2011). On the other hand, studies looking at OR trafficking in 
heterologous expression systems have shown that these receptors undergo constitutive 
internalization via a clathrin-dependant mechanism (Jacquier et al., 2006; Mashukova et al., 
2006) with subsequent endosomal recycling, suggesting a similar mechanism in OSNs could 
be instrumental to allow rapid recovery of odour perception (Jacquier et al., 2006). 
 
1.2. Sperm 
1.2.1. Spermatogenesis and sperm structure 
In humans, the production of mature male gametes from spermatogonial sperm cells – 
spermatogenesis – is initiated with puberty and constitutes a highly ordered and complex 
process that maintains a constant supply of male gametes throughout adult life.  
Sperm production occurs in the testis, within the seminiferous epithelium, which consists of 
Sertoli cells (somatic cells) and several types of germ cells. The whole spermatogenesis takes 
around 64 days (Heller and Clermont, 1963) and is the totality of four sequential processes 
(Figure 1.4): spermatogonial development (stem cell and subsequent cell mitotic divisions – 
Figure 1.4, cell types 1-3), meiosis (DNA synthesis and two meiotic divisions to yield haploid 
spermatids – Figure 1.4, cell types 3-5), spermiogenesis (spermatid development involving 
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differentiation of head and tail structures – Figure 1.4, cell types 5-6), and spermiation (the 
process of release of mature sperm into the tubule lumen – Figure 1.4, cell type 7) 
(McLachlan et al., 2002). 
 
 
Figure 1.4 – Schematic representation of human spermatogenesis 
Adapted from Phillips and Tanphaichitr, 2010 
 
Regulation of spermatogenesis involves both intrinsic and extrinsic components. Intrinsic 
regulation relies on the effects of testosterone, growth factors and other neurocrine 
substances secreted by Leydig and Sertoli cells to control an intricate circle of regulation of 
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cell functions and development of germ cells, but also other functions like peristaltic 
movement of the seminiferous tubules (sperm transport) and blood flow in the itertubular 
vasculature (Middendorff et al., 1997). This local regulation is itself controlled by external 
stimuli: follicle stimulating hormone (FSH) secreted by the anterior pituitary gland stimulates 
Sertoli cells and is essential for the maturation of germ cells, whereas gonadotropin 
releasing hormone (GnRH) secreted by the hypothalamus triggers release of luteinizing 
hormone (LH) by the hypophysis, which in turn promotes testosterone production by Leydig 
cells. Testosterone levels will influence not only local events but also provide feedback to the 
hypophysis about the secretory activity of Leydig cells (Holstein et al., 2003).  
 
 
Figure 1.5 – Human sperm cell structure 
a. diagrammatic view of a human spermatozoon; b, c and d. flagellum cross-sections at midpiece, principal piece and end 
piece, respectively. Adapted from Gaffney et al. In Press 
 
The mature human spermatozoon is a relatively small and highly polarised haploid cell 
(Figure 1.5) comprising two major regions: the tail, used for energy production and initiation 
and maintenance of motility to drive the gamete to the fertilisation site, and the head, 
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crucially carrying all the genetic material and mechanisms necessary for zona recognition 
and sperm-egg fusion (Curry and Watson, 1995). In terms of organelles, the sperm cell is 
very efficient, including only the absolutely indispensable for its journey: the head consists of 
a nucleus, where the DNA is very tightly packed, and a single large secretory vesicle – the 
acrosome, storing a number of different hydrolytic enzymes crucial for penetrating the zona 
pellucida. The flagellum includes a mitochondria powerhouse in the midpice, providing all 
the energy required for motility and other cellular processes, and an axoneme, which 
stretches the full length of flagellum and constitutes the motor apparatus of the sperm tail. 
The whole cell is contained by the plasma membrane but, characteristically, spermatozoa 
lack other major cytoplasmic organelles such as the Golgi apparatus and endoplasmic 
reticulum. Despite recent and controversial evidence supporting nuclear gene expression in 
mammalian sperm involving 55S mitochondrial ribosomes (Gur and Breitbart, 2006), the 
general view, supported by earlier work looking at incorporation of radiolabeled amino acids 
(Engel et al., 1973; Hernandez-Perez et al., 1983), is that spermatozoa are devoid of any 
major transcriptional and translational activity (Baker et al., 2005; Blaquier et al., 1988a; 
Blaquier et al., 1988b; Naz and Rajesh, 2004; Ross et al., 1990). 
 
1.2.2. Maturation and capacitation 
When spermatozoa are released from the seminiferous epithelium of the testis they have 
already undergone a lengthy development, from undifferentiated germ cells to highly 
compartmentalised and specialised ones. However their developmental process is not 
completed yet: their journey out of the testis, through the seminiferous tubules, epididymis 
and vas deferens, before eventual ejaculation, can take several weeks. This process will add 
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functional aptitudes to cells that would otherwise lack motility and therefore fertilising 
ability: during their transit through the epididymis, in a process referred to as maturation, 
sperm will undergo a series of changes that culminate in the acquisition of progressive 
motility and the ability to capacitate (Cooper, 1995). Importantly, these events include 
addition of crucial function-modulating non-sperm expressed (epididymal) proteins into the 
maturing sperm proteome, such as the cysteine-rich secretory proteins (Ellerman et al., 
2006; Gibbs et al., 2006; Nolan et al., 2006). At the time of ejaculation sperm are further 
mixed with seminal vesicle and prostate secretions during deposition at the cervix, and again 
at this stage, additional proteins and signaling modulators may be added to the sperm from 
so-called prostasomes – membrane-bound vesicles derived from prostate epithelial cells 
(Arienti et al., 2002; Arienti et al., 2004; Palmerini et al., 2003). A recent study by Park et al., 
2011 has found evidence of several molecules involved in Ca2+ signaling like progesterone 
(PR) and ryanodine receptors (RyRs), secretory pathway Ca2+ ATPases (SPCAs) and cyclic 
adenosine diphosphoribose (cADPR)-enzymes being transferred from prostasomes to the 
sperm midpiece, correlating interference with these molecules to reduced sperm motility 
and /or infertility. 
Before they are fully equipped for their ultimate purpose, however, freshly ejaculated 
spermatozoa must undergo a series of parallel functional and structural changes imposed by 
the female reproductive tract, in a complex series of events known as capacitation, which 
eventually grant them their fertilising capacity (Austin, 1952; Chang, 1952; Chang, 1984).  
Transition from uncapacitated to capacitated state is thought to involve removal of 
decapacitation factors (DFs) from the external surface of decapacitation factor receptors 
(DF-R) (Fraser et al., 2006). Attempts to characterise these molecules in mouse sperm have 
14 
 
identified an anionic protein of about 40kDa associated with fucose residues important for 
function (Fraser, 1998). More recently Bi and colleagues (Bi et al., 2009) have identified a 
new PLCζ1 isoform - NYD-SP27, which belongs to the  PLCζ family but lacks the EF domains in 
its N terminus. This work reports NYD-SP27 localises to the acrosome in human and mouse 
sperm, and detaches from sperm as they go through capacitation and AR, therefore 
suggesting NYD-SP27 as a physiological inhibitor of PLC that acts as an intrinsic 
decapacitation factor, regulating capacitation and AR. Further work by Fraser’s group also 
revealed that DF binds to a second protein (DF-R) which shows high homology with 
phosphatidylethanolamine-binding protein 1 (PEBP 1) and attaches to the sperm surface via 
a glycosylphosphatidylinositol (GPI) anchor (Gibbons et al., 2005). Whether DF is bound to 
DF-R or not is hypothesized to alter sperm plasma membrane architecture, together with the 
conformation and function of membrane-associated proteins like Ca2+-ATPase and 
stimulatory and inhibitory GPCRs, controlling cytosolic levels of second messenger cAMP via 
membrane-associated adenylyl cyclase mAC, and therefore regulating downstream tyrosine 
phosphorylation and sperm function (Fraser, 2010). 
In human in vitro work, capacitation is marked by tyrosine phosphorylation events (Ficarro 
et al., 2003; Luconi et al., 1995) or assessed as an ability to fuse with the oocyte. 
Understandably, in vivo work is a lot sparser, and signals undeniably more complex. These 
signals are mediated by a diverse molecular array, where players like calcium, bicarbonate, 
serum albumin, glycodelins and other endogenous factors (Bjorndahl et al., 2006; De Jonge, 
2005; de Lamirande et al., 1997; Ford, 2004; Fraser et al., 2006; Yanagimachi, 1994; Yeung et 
al., 2009) seem to have centre stage roles. These molecules are present at different levels in 
different female tract fluids, but detailed molecular mechanisms and chain of events leading 
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to sperm capacitation are yet to be unravelled. One of the major changes sperm are exposed 
to is a significant shift in ion fluxes, which in turn determines subsequent plasma membrane 
potential: prior to ejaculation, caudal epididymal sperm are stored in a high potassium, low 
sodium and very low bicarbonate environment. These ion concentrations, however, change 
dramatically on ejaculation, first in the seminal fluid and afterwards in the female 
reproductive tract, with both bicarbonate and sodium increasing considerably and 
potassium being significantly reduced (Brooks, 1983; Yanagimachi, 1994). In vitro work with 
boar spermatozoa has demonstrated an initial rapid PKA-dependant protein phosphorylation 
via activation of sAC by bicarbonate-containing medium, along with a later increase in 
tyrosine phosphorylation (Harrison, 2004). These events are thought to activate a 
phospholipid scramblase, resulting in significant reduction in membrane stability (Gadella 
and Harrison, 2002), crucially allowing cholesterol removal from the plasma membrane. This 
cholesterol loss, facilitated by extracellular albumin acting as cholesterol acceptor (Visconti 
et al., 1999), can directly or indirectly affect the cell’s capacitation state, via modulation of 
intracellular pH, changes in membrane fluidity and fusibility, and potential exposure of 
membrane receptors important in sperm-zona interaction and acrosome reaction (Cross, 
1998), therefore representing a major event in controlling subsequent sperm function.  
Another stepping stone in sperm capacitation is hyperactivation. This physiological state, 
first described in mammalian sperm by Yanagimachi, 1970, is characterised by cells 
displaying very active thrusting, together with high amplitude, asymmetrical flagellar 
bending. As reviewed by Suarez, 2008, hyperactivated motility is set off by a rise in flagellar 
calcium levels, primarily mediated by plasma membrane CatSper channels, and appears to 
be required for successful zona pellucida penetration. Additionally, in many species 
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hyperactivation has also been suggested to play an important role in facilitating sperm 
release from the oviductal storage reservoir, as well as their progression through the mucus 
present in the oviductal lumen and the cumulus oophorus.  
 
1.2.3. Acrosome reaction 
Sperm’s acrosome is a sizeable membrane-limited secretory organelle derived from the 
Golgi that houses a complex of enzymes and overlies the nucleus in the apical region of the 
sperm head (Yanagimachi, 1994). This vesicle is the key player in a major exocytotic event 
essential for fertilisation, leading to the release of acrosomal enzymes and exposure of 
molecules in the inner acrosomal membrane surface known as acrosome reaction (AR) 
(Figure 1.6). The release of the acrosome’s contents starts with point fusions between outer 
acrosomal membrane and overlying plasma membrane. This releases the acrosome’s lytic 
content, thus facilitating the carving of a path through the oocyte’s vestments.  
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Figure 1.6 – Acrosome reaction in human sperm 
General features of the human sperm acrosome before (acrosome intact), during (acrosome reaction intermediates) and 
after (acrosome reacted) acrosome reaction. PM – plasma membrane; AM – acrosomal membrane. (Adapted from 
Wassarman and Litscher, 2008) 
 
In human, the first barrier between the spermatozoon and the oolema is the cumulus 
oophorus, a hyaluronic acid-rich layer of cumulus cells surrounding the ovulated oocyte, 
consisting of an outer cell layer (cumulus cells) and an inner cell layer (cells of the corona 
radiata). The passage through the cumulus is thought to prime sperm cells for AR (Tesarik et 
al., 1988), and those that successfully negotiate it will then encounter the next vestment: the 
zona pellucida (ZP). ZP is a specialised matrix of the egg, made up of different glycoproteins 
(ZP1-ZP4), that serves roles as important as species-restricted recognition between gametes, 
prevention of polyspermy and protection of the embryo before implantation (Yanagimachi, 
1994). The well-studied mouse ZP model consists of filaments of repeated ZP2-ZP3 
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heterodimers occasionally cross-linked by ZP1, forming a mesh-like structure (Dean, 2007), 
whereas in the human an additional protein (ZP4) similar to ZP1 (both in function and 
structurally) has also been identified (Lefievre et al., 2004). Mouse ZP3 has been found to be 
crucial for fertilisation by acting as a receptor for sperm (Wassarman and Litscher, 2008) and 
inducer of AR (Beebe et al., 1992) and this is thought to be the case for other mammalian 
species including human (van Duin et al., 1994). 
In order to undergo AR in response to physiological stimuli spermatozoa must be 
capacitated: physiological AR is dependent on many of the same effectors of capacitation, 
and intracellular signaling involved in AR starts to be tuned during capacitation (de 
Lamirande et al., 1997). The dogma states that in most species the fertilising spermatozoon 
undergoes AR very close to, or on the zona pellucida (Cummins, 1995). However, recent 
evidence suggests that, at least in the mouse, this might not be the case: Jin and colleagues 
(Jin et al., 2011) demonstrated that fertilising mouse spermatozoa begin the acrosome 
reaction before reaching the zona pellucida of cumulus-enclosed oocytes. Furthermore, this 
work has also shown that the incidence of in vitro fertilisation of cumulus-stripped oocytes is 
increased when these are incubated with cumulus cells, pointing to an important role of the 
cumulus matrix in vivo. As reviewed by Kirkman-Brown et al., 2002, the effects of cumulus 
cells on spermatozoa in vivo are still largely unknown, but the fact that the cumulus secretes 
progesterone at levels sufficient to trigger AR in capacitated human sperm (De Jonge et al., 
1988; Osman et al., 1989) could relate to Jin’s recent findings in mouse (Jin et al., 2011) and 
support the idea of cumulus as AR inducer in vivo.  
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1.2.4. Motility, transport and interactions with the female reproductive tract 
For fertilisation to occur, spermatozoa must be able to navigate their way through the 
female reproductive tract (FRT) and reach the fertilisation site. In the human this translates 
into a journey several thousand times the spermatozoon’s body length through a viscous 
and constantly changing environment. Sperm need to penetrate the cervix through the 
cervical mucus, an FRT’s secretion whose viscosity is regulated by endocrine control (Kremer 
and Jager, 1988), therefore constricting its permeability to sperm to the female’s fertile 
period. After penetrating the cervix spermatozoa need to traverse the uterus, find the 
correct oviductal opening (20 -50 µm in diameter) and make their way to the fertilisation site 
through the ciliated and highly convoluted surface of the oviduct, to which a series of 
transient binding events may occur, although a site of true sperm storage has yet to be 
demonstrated (Baillie et al., 1997; Morales et al., 1996; Pacey et al., 1995; Williams et al., 
1993). Ultimately, sperm’s journey through the FRT, culminating in fertilisation, constitutes a 
strict selection process through which a population of millions is reduced to a single cell, and 
success is conditional to exhibiting the right motility at the right moments. Certainly, the FRT 
plays a crucial role in the regulation of the spermatozoon’s different motilities and correct 
synchronisation of crucial events like capacitation, hyperactivation and AR (Suarez and 
Pacey, 2006).  
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from Yeung et al., 2009 
 
Figure 1.7 - Glycodelin glycoforms modulate sperm function in the female reproductive tract 
 
 
Throughout their journey, spermatozoa may follow several signals presented by the FRT, 
including temperature, fluid flow, and chemical cues (Eisenbach and Giojalas, 2006), and at 
the same time their function will be delicately modulated by most of those signals. One of 
the molecules mediating this modulation is glycodelin, a glycoprotein with four known 
glycoforms, differing only in their glycosylation. As recently reviewed by Yeung et al., 2009, 
during their journey to the oocyte, sperm are exposed to these different glycoforms in a 
21 
 
sequential manner (Figure 1.7). Glycodelin-S, isolated from seminal plasma, is the only male 
glycoform identified to date and inhibits albumin-induced cholesterol efflux from the plasma 
membrane. This prevents sperm from capacitating before their passage through the cervix, 
where glycodelin-S is removed from the cell surface by interaction with the cervical mucus 
(Chiu et al., 2005). Oviduct-produced Glycodelin-A (isolated from amniotic fluid) and 
glycodelin-F (isolated from follicular fluid) have similar activity, both inhibiting spermatozoa-
zona pellucida binding (Chiu et al., 2003b; Oehninger et al., 1995). More importantly, 
glycodelin-F prevents premature acrosome reaction induced by progesterone secreted by 
the granulosa and cumulus cells (Chiu et al., 2003a), whereas glycodelin-A primes sperm for 
zona pellucida-induced AR. Their combined actions allow for a timely start of AR, essential 
for successful fertilisation. Glycoforms F and A are likely to be converted later to glycoform C 
by the cumulus cells (Chiu et al., 2007; Tse et al., 2002), resulting in the displacement of 
glycodelins F and A and enhancement of sperm-zona pellucida binding (Chiu et al., 2007). 
 
1.2.5. Possible guidance mechanisms in the mammalian female reproductive tract 
In mammals, the chance for interaction between male and female gametes is mostly 
dependent on the male gamete, and fertilisation is only possible if sperm prove able to 
successfully overcome the series of difficulties presented by a hostile and long journey 
through the female reproductive tract. However, in this context, it is widely accepted that all 
along this journey spermatozoa are being presented with a series of cues by the FRT, which 
are used in a set of distinct guidance mechanisms that allow sperm to navigate their way to 
the oocyte. Two active guidance mechanisms – chemotaxis and thermotaxis – have been 
described as significant in allowing sperm to reach the fertilisation site (reviewed in 
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Eisenbach and Giojalas, 2006 - see Figure 1.8), although passive sperm transport by muscular 
activity of the vagina, cervix and uterus, together with ciliar movement by oviductal 
epithelial cells, is also thought to be important in sperm migration in the FRT. 
 
 
from Eisenbach and Giojalas, 2006 
 
Figure 1.8 – Sperm guidance mechanisms within the mammalian female reproductive tract 
Diagrammatic representation of the mammalian female reproductive tract, illustrating possible sperm guidance 
mechanisms. Organ dimensions presented are derived from studies in human (Harper, 1982) and temperatures were 
measured in rabbits (Bahat et al., 2005). 
 
Chemotaxis, the directional movement of cells along a chemical gradient, has been 
thoroughly investigated in marine invertebrates (Kaupp et al., 2006), but the overall 
understanding of this phenomenon in mammals if much more limited. Nevertheless, the 
evidence that chemotaxis indeed has a significant role in human and other mammals has 
been building for some time now, with several groups reporting mammalian spermatozoa as 
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chemotactically active towards follicular fluid (Fabro et al., 2002; Giojalas and Rovasio, 1998; 
Oliveira et al., 1999; Ralt et al., 1991; Villanueva-Diaz et al., 1990), substantiating chemotaxis 
as a physiologically relevant and widespread guidance mechanism also in organisms with 
internal fertilisation. Unlike in marine invertebrates, however, only a subpopulation of 
capacitated mammalian spermatozoa is considered to be chemotactically active at any given 
time (Cohen-Dayag et al., 1994; Cohen-Dayag et al., 1995; Fabro et al., 2002; Oliveira et al., 
1999). The identity of the molecule/s responsible for physiological chemotaxis in human 
sperm remains contentious: progesterone has been suggested as the chemoattractant in 
follicular fluid, with recent work by Teves et al., 2009 reporting pM concentrations of the 
steroid as capable of triggering chemotaxis in human sperm, whereas earlier work (Jaiswal et 
al., 1999; Ralt et al., 1991) describes progesterone as chemotactically inactive at the 
concentration range sperm are most likely to encounter in the female reproductive tract 
(Munuce et al., 2006). A different line of research suggests sperm could be attracted towards 
chemicals secreted by either by the egg-cumulus complex or the FRT itself. Evidence of 
human and mouse sperm being chemotactically attracted towards synthetic odorous 
molecules in vitro (Fukuda et al., 2004; Spehr et al., 2003) have prompted the authors to 
propose the receptors involved in the chemotactic events observed in vitro could be 
stimulated by molecules similar to the synthetic odorants tested.  
Chemotactic effects from any potential chemoattractant within the FRT will certainly be 
limited to a length scale of around 1cm from the source of the chemoattractant molecule, so 
a more elaborate multi-step chemotaxis phenomenon involving different chemoattractants 
exerting their effects at different stages of the journey to the fertilisation site is considered 
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to be a more likely mechanism allowing sperm guidance towards the egg (Eisenbach and 
Giojalas, 2006).  
The molecular mechanisms ruling mammalian sperm chemotaxis are still poorly understood, 
mostly due to the uncertainty over the molecules involved and the difficulty in designing 
relevant experimental methods with physiological significance, however, in vitro 
observations have provided a common basis for the mammalian chemotactic response 
where the importance of cyclic nucleotides and subsequent Ca2+ transients seem to be a 
commonality between marine species and mammals (Eisenbach and Giojalas, 2006; Kaupp 
et al., 2006; Spehr et al., 2006).  
Thermotaxis is another guidance mechanism which some mammalian sperm have been 
reported to use to navigate from the isthmic region of the fallopian tube (where sperm 
storage is thought to occur in species like the bovine, swine and ovine) to the site where 
fertilization eventually occurs. Temperature measurements within pig fallopian tubes have 
revealed a temperature gradient to be present between the caudal isthmus and the cranial 
portion of the ampulla during early estrus of mated animals. The former proved cooler that 
the later by an average of 0.7°C, and this difference was no longer present shortly after 
ovulation (Hunter and Nichol, 1986). These differences in temperature are thought to reflect 
the differential activities of the vascular and lymphatic beds, as well as muscular activity 
related to peristaltic contractions by the oviduct on different phases of the menstrual cycle. 
Another possible temperature modulator could be the chemical microenvironment within 
the in the caudal isthmus, where sperm are stored for relatively long periods before 
fertilisation. This area might be the stage of endothermic reactions generated in the viscous 
glycoprotein secretions that accumulate before ovulation. During and after ovulation, a 
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temperature increase in the storage region would facilitate activation and release of 
maturing spermatozoa, thus providing adequate number of spermatozoa for successful 
fertilization to occur (Hunter, 2009). Furthermore, both rabbit and human sperm have also 
been shown to sense temperature differences as low as 0.5°C and swim from the cooler to 
the warmer temperature (Bahat et al., 2003) in a thermotactic response which, similar to the 
chemotactic responses in mammalian sperm, is only observed in capacitated cells, therefore 
suggesting thermotaxis could play a role in sperm navigation within mammalian species. 
 
1.2.6. Cell signaling in mammalian spermatozoa 
Spermatozoa are highly specialised cells and are generally accepted as translationally / 
transcriptionally inactive. Unlike somatic cells, spermatozoa are largely dependent on post-
translational modification of “inherited” proteins for the regulation of their cellular 
processes. This non-genomic regulation involves a fine balance between levels of 
intracellular messengers like cAMP, cGMP, nitric oxide and calcium. All these messengers 
play important roles in crucial cell processes like capacitation (Breitbart, 2002; Hess et al., 
2005), but as reviewed by Publicover et al., 2007, calcium takes centre stage in sperm cell 
signaling. Free calcium levels in the cytoplasm are maintained very low, and signaling 
involves modulating membrane channels that control Ca2+ flux between the cytosol and 
either the extracellular milieu or intracellular calcium stores, where Ca2+ levels are up to four 
orders of magnitude higher (Costello et al., 2009). [Ca2+]i is pivotal for sperm function, 
regulating crucial events like AR (Evans and Florman, 2002; Kirkman-Brown et al., 2002), 
hyperactivation (Harper et al., 2004; Suarez, 2008) and potentially chemotaxis (Spehr et al., 
2003), being also important in sperm capacitation (Breitbart, 2002; Fraser, 2010). Although 
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spermatozoa lack a functional endoplasmic reticulum, the main, but by no means the only 
Ca2+ storage organelle in somatic cells (Michelangeli et al., 2005), any or several of the 
intracellular membranous sperm structures can potentially work as Ca2+ store, provided they 
include the relevant molecular machinery (recently reviewed by Costello et al., 2009), 
therefore allowing sperm to maintain high levels of non-cytosolic intracellular Ca2+.  
 
 
from Publicover et al., 2008 
 
Figure 1.9 – [Ca
2+
]i regulation mechanisms in sperm 
Distribution of the molecular machinery involved in the regulation of [Ca
2+
]i in mammalian sperm. Channels are represented 
as rectangles, pumps as circles and arrows represent normal Ca
2+
 flow direction. 
 
The molecular machinery involved in the regulation of [Ca2+]i includes several classes of 
membrane receptors and ion pumps (Figure 1.9). These molecules are unevenly distributed 
in different regions of the plasma membrane and intracellular stores, and allow sperm to 
generate complex and apparently localized [Ca2+]i signals (Publicover et al., 2008). Present at 
the plasma membrane we can find voltage-operated Ca2+ channels (VOCCs), transient 
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receptor potential channels (TRPCs), cyclic nucleotide-gated channels (CNG) and cation 
channels of sperm (CatSper), whereas intracellular calcium stores regulate the release of 
Ca2+ to the cytosol via ryanodine receptors (RyR) and inositol triphosphate (IP3) receptors 
(IP3Rs). These Ca
2+ -permeable channels open in response to extra or intracellular stimuli 
allowing ions to flow down their electrochemical gradient, and therefore initiating a [Ca2+]i 
signal with virtually no energy consumption. On the other hand, the maintenance of a low 
[Ca2+]i level is mainly dependent on the action of energy-driven ion pumps that clear calcium 
from the cytoplasm to intracellular Ca2+ stores or to the extracellular space. In mammalian 
sperm there are three types of Ca2+ pumps: the plasma membrane calcium ATPases 
(PMCAs), the sarcoplasmic-endoplasmic Ca2+ ATPases (SERCAs) and the secretory pathway 
Ca2+ ATPases (SPCAs) (Michelangeli et al., 2005). Furthermore, both the sodium/calcium 
exchanger (NCX) and mitochondrial Ca2+ uptake can also contribute to maintain low cytosolic 
Ca2+ levels (Jimenez-Gonzalez et al., 2006). 
Another crucial signaling mechanism in mammalian sperm is protein phosphorylation. As 
these cells are unable to synthesise new protein, post-translational modification of the 
existent protein array plays a fundamental role in regulating phenomena like capacitation 
and AR. Protein phosphorylation/dephosphorylation is reguated by the activity of kinases 
and phosphatases, and their counteracting activities provide  cells with an effective switch 
that can turn the funtion of various effector proteins on or off, depending on their 
phorphorylation state. 
Although phosphorylation of other protein residues like serine and threonine have been 
reported in spermatozoa, tyrosine phosphorylation has proved to be the main 
28 
 
phosphorylation event, being implicated in the regulation of major events like capacitation, 
hyperactivated motility, binding to the zona pellucida and AR (Naz and Rajesh, 2004).  
An increase in protein tyrosine phosphorylation has been observed during capacitation of 
many mammalian species' sperm, and this increase is reported to be mediated by a cAMP-
mediated pathway (Naz and Rajesh, 2004). Sperm's flagellum seems to be the major 
component of sperm to undergo a specific sequence of phosphorylation in most mammalian 
species. In human spermatozoa, protein A-kinase anchoring proteins (AKAPs), localised to 
the fibrous sheath, are the most prominent protein group undergoing tyrosine 
phosphorylation during capacitation (Carrera et al, 1996).  
Tyrosine phosphorylation events were shown to be related to the acquisition of 
hyperactivated motility, and interestingly, the level of tyrosine phosphorylation in 
capacitating sperm was shown to be modulated by interaction with oviductal epithelial cells, 
indicating these interactions might be important to help synchronize sperm function with 
the time of ovulation (Petrunkina et al, 2003). 
Adding to the already mentioned signaling mechanisms, sperm function can also be 
regulated by reactive oxygen species (ROS), which include reduced forms of oxygen and their 
reaction products with other molecules. As reviewed by Ford, 2004, ROS have been reported 
to promote capacitation in sperm from several mammalian species, with the in vitro addition 
of ROS generally causing increase in capacitation levels across most of the studies reviewed. 
Furthermore, ROS have also been implicated in sperm maturation, by facilitating nuclear 
condensation (Aitken and Vernet, 1998), and motility initiation, by enhancing cAMP 
synthesis and protein phosphorylation (Aitken, 2000). One of the best studied ROS in sperm 
is nitric oxide (NO): since the discovery that this gas could act as an intracellular messenger 
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(Palmer et al., 1987), and as recently reviewed by Lefievre et al., 2009, research has 
suggested an important role for NO in the communication between the FRT and sperm 
approaching the fertilisation site, since NO is actively synthesised both the tract epithelium 
and the cumulus-oocyte complex (Ekerhovd et al., 1999; Lapointe et al., 2006; Tao et al., 
2004), and at low concentrations, to cause motility changes in sperm and possibly act as a 
chemoattractant (Herrero et al., 1994; Miraglia et al., 2007; Zhang and Zheng, 1996). The 
signaling mechanisms involved are not fully understood, but NO mode of action involves 
activation of soluble guanylate cyclase, leading to kinase activation and ion channel gating 
(Cary et al., 2006), but also protein nitrosylation, which acts as a switch to protein 
phosphorylation (Mannick and Schonhoff, 2004).  
 
1.2.7. Progesterone and intracellular calcium 
The signaling events that occur upon exposure of sperm to progesterone are complex and at 
present still confusing. However, a universally reported finding is that treatment with 
progesterone causes a transient elevation of [Ca2+]i, often followed by a sustained elevation 
(Aitken et al., 1996; Baldi et al., 1991; Blackmore et al., 1990; Bonaccorsi et al., 1995; 
Clapham, 1995; Kirkman-Brown et al., 2000; Tesarik et al., 1996). Importantly, induction of a 
rapid elevation in [Ca2+]i upon in vitro exposure to a bolus of progesterone in the 0.3 nM to 3 
µM leads to AR in humans (Harper et al., 2003; Kirkman-Brown et al., 2002), and this 
concentration range does relate to physiological progesterone levels sperm might encounter 
along the oviduct and near the fertilisation site (Munuce et al., 2006; Oehninger et al., 1994). 
Additionally, progesterone has been implicated in sperm guidance (Eisenbach and Giojalas, 
2006; Oren-Benaroya et al., 2008; Teves et al., 2009), mobilisation of intracellular calcium 
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stores leading to complex calcium signaling (Publicover et al., 2007), and also in potentiating 
ZP-induced AR in human sperm (Morales et al., 2002; Schuffner et al., 2002), indicating a role 
for this steroid in initiating a stable but intermediate stage of “AR-readiness” before crucial 
ZP-induced acrosomal exocytosis.  
When previously reviewed (Correia et al., 2007), the identity of receptor molecules involved 
in progesterone-evoked signaling events was still not clear, although evidence seemed to 
indicate a SERBP1/PGRMC1 complex as the most likely functional progesterone receptor in 
sperm. However, recent evidence by two independent labs (Lishko et al., 2011; Strunker et 
al., 2011) applying patch-clamp to mature human sperm has revealed CatSper, a pH-
dependent Ca2+ channel of the sperm flagellum, as the most likely receptor mediating non-
genomic actions of progesterone, although effects via other steroid binding receptors and 
ligand-gated ion channels cannot be excluded. Both reports demonstrate a rapid activation 
of CatSper by progesterone, incompatible with signal transduction involving metabotropic 
receptors and second messengers. Whether progesterone binds directly to the channel or to 
a different protein which associates with CatSper forming a channel/receptor complex is still 
uncertain, but the recent findings by Lishko and Strunker constitute a major advance in the 
understanding of the non-genomic actions progesterone evokes in sperm.  
 
1.3. Aims of the research 
The current work aimed to characterise the most prevalent OR in mature human sperm 
(OR2AE1) and investigate potential roles it might play in sperm biology. The strategy 
involved cloning the receptor and the expression on a heterologous system which would 
allow the screening of a large odorant library for potential receptor agonists. These were 
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then to be tested with human sperm to identify and characterise possible physiological and / 
or functional effects on these cells, with the ultimate purpose of enriching our 
understanding of a research area which is still on its infancy. In a different approach, and 
relating to other lines of research within our lab, a similar characterisation was anticipated 
for unrelated compounds (boronic acids) which had previously showed promise in enhancing 
sperm motility. 
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2. CHARACTERISATION OF OLFACTORY RECEPTORS 
EXPRESSED IN HUMAN SPERMATOZOA 
2.1. Introduction 
From the discovery of ORs two decades ago (Buck and Axel, 1991), evidence of these 
receptors being expressed in tissues unrelated to olfaction is copious (see section 1.1.4). The 
finding that ORs are also expressed in mammalian mature sperm (Baker et al., 2007; Lefievre 
et al., 2007; Spehr et al., 2004; Vanderhaeghen et al., 1993) was of particular interest for 
reproductive biologists as it opens new perspectives for a possible functional role these 
receptors might be playing in reproduction. Given the particularities of mature sperm and 
that these cells are translationally and transcriptionally inactive, the fact that during 
spermiogenesis resources are invested in arming them with OR proteins, increases the 
likelihood that these receptors must serve a purpose within the general reproductive 
marathon.  
Following on pioneering work in which Wetzel and colleagues were able to match the first 
human olfactory receptor (OR17-40) to its agonist helional (Wetzel et al., 1999), the same 
group later published a landmark paper implicating a testicular OR (OR1D2) in the 
chemotactic response elicited by the odorant bourgeonal in mature human sperm (Spehr et 
al., 2003). These and subsequent works (Spehr et al., 2004; Veitinger et al., 2011) combined 
screening of odorant libraries and heterologous expression of ORs in HEK293 cells (Graham 
et al., 1977) to successfully identify agonists for orphan human ORs via single-cell Ca2+ 
imaging.  
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As reviewed by Mombaerts, 2004, other groups have taken different approaches to match 
odorants to cloned ORs, but the few success stories for human ORs were achieved using 
variations of Wetzel’s strategy. The current work applied the same core strategy to 
effectively identify an agonist for OR2AE1, an olfactory receptor previously identified in 
mature human sperm (Baker et al., 2007; Lefievre et al., 2007). 
 
2.2. Material and Methods 
2.2.1. OR cloning and vector design 
Both OR genes featured in this study were amplified from genomic DNA by PCR and initially 
cloned into pGEM-T Easy vector (Promega Corporation, USA). Primers used for OR2Y1 (Gene 
ID 134083) were: forward = ATGGGAAGTTTCAACACC; reverse = CTACCCTGAGTCCCTGC. 
Primers for OR2AE1 (Gene ID: 81392) were: forward = ATGTGGCAGAAGAATCAGACCTC; 
reverse = CTACACTCGGGGCAACCACAAT. Resulting clones were then sub-cloned into 
mammalian expression vectors after assessment for the correct sequence by at least four 
sequencing runs. OR2AE1’s sequence, including the final stop codon, was inserted into 
pEGFP-N2 (Clontech – Becton Dickinson Biosciences, USA), out of frame with the EGFP gene 
so no chimeric expression of the OR was possible with EGFP (Figure 2.1), whereas OR2Y1’s 
sequence was sub-cloned into pcDNA3 (Invitrogen Life Technologies, USA) (Figure 2.2).  
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Figure 2.1 – FLAG-OR2AE1 plasmid. 
OR2AE1 sub-cloned into mammalian expression vector pEGFP-N2 between SpeI and BamHI restriction sites. Construct 
coding for CRHR1 and FLAG inserted between SacI and SpeI. 
 
 
 
Figure 2.2 – FLAG-OR2Y1 plasmid.  
OR2Y1 sub-cloned into mammalian expression vector pcDNA3 between KpnI and NotI restriction sites. Construct coding for 
CRHR1 and FLAG inserted between HindIII and KpnI. 
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Both mammalian expression vectors used were subsequently modified to include a single 
ORF expressing the ORs as N-terminal fusions with: 1) signaling peptide of human 
corticotropin releasing hormone receptor 1 (CRHR1), which is removed in the endoplasmic 
reticulum, and has been reported to enhance GPCR plasma membrane trafficking in HEK293 
cells (Ladds, 2009); 2) FLAG tag, which, by being adjacent to the N-terminal chain of the OR, 
localises extracellularly, therefore allowing to check for receptor expression at plasma 
membrane level. All clones used where screened for correct restriction enzyme profile and 
sequence. 
 
2.2.2. Cell culture and transfection 
Human Embryonic Kidney 293 cells (HEK293) (Graham et al., 1977) were maintained at 37 
°C, 95% air – 5% CO2 in high glucoseDulbecco's Modified Eagle Medium (D-MEM - 
DULBECCO and FREEMAN, 1959) (Gibco/Invitrogen, USA) supplemented with 10% heat-
inactivated foetal bovine serum (FBS, Biosera, Ringmer, UK).  
Initially, transient transfection conditions were assessed using pEGFP-N2 with no insert, 
which expresses a red-shifted variant of wild-type GFP, allowing for transfection rate 
quantification by detection of fluorescence within the green range. GeneJuice (Novagen, 
USA) was used to transiently transfect semiconfluent cells (50-80%) and conditions were 
optimized to transfection of 2 µg of plasmid DNA per 35 mm dish (Falcon 353001, Becton 
Dickinson, NJ, USA), 24 h after plating and 24 h before single cell calcium imaging 
experiments.  
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For each calcium imaging experiment, two parallel sets of cells were produced, one 
transfected with OR-containing plasmid (receptor-transfected cells) and another transfected 
with the plasmid without an insert (mock-transfected cells).  
 
2.2.3. Heterologous OR expression – plasma membrane localisation 
In order to assess whether transfected ORs were being expressed at the plasma membrane 
of HEK293 cells, and as described in 2.2.1, recombinant ORs included an N-terminus FLAG 
tag. ORs correctly localized to the membrane would therefore include FLAG on extracellular 
N-terminus chain, allowing for immunodetection with an anti-FLAG antibody (Webster et al., 
2005).  
 
 
Figure 2.3 – Recombinant FLAG-OR2AE1  
Functional expression of recombinant OR2AE1 incorporating FLAG tag on the extracellular N-terminus chain. 
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HEK293 cells were transiently transfected with FLAG-OR2AE1 plasmid as described (2.2.2), 
fixed with 4% paraformaldehyde (37 :C, 30 minutes), blocked with 1% BSA (37 :C, 30 
minutes) and incubated at room temperature for one hour with primary antibody (5µg/ml 
mouse monoclonal FLAG Tag antibody – autogenbioclear, UK). Cells were the incubated with 
FITC-conjugate anti-mouse IgG antibody (F0257 – Sigma, UK) for one hour at room 
temperature and detection of fluorescence was done at 40X magnification using a Nikon 
TE300 inverted microscope illuminated with a blue LED – 470 nm (CAIRN Research Ltd, UK) 
coupled to a Photometrics Quant-Em 512 CCD camera. 
 
2.2.4. Single cell calcium imaging and odorant exposure 
Ligand screening for receptors expressed in the heterologous system consisted of 3 
consecutive steps, having Wetzel’s odorant screening strategy (Wetzel et al., 1999) as base. 
An odorant library including one hundred odorous chemicals (Henkel 100; Henkel, 
Dusseldorf, Germany) from several classes and groups (aromatics, aliphatics, alcohols, 
aldehydes, esters, ethers, ketones, amines, alkanes, heterocyclics and others) was 
subdivided into submixtures, each with increasingly smaller numbers of odorants (Figure 
2.4). The first step of the screening strategy involved dividing Henkel 100 into two mixtures 
with 50 odorants each and screens these for the ability of triggering calcium responses in 
receptor-transfected cells. These two mixtures were further divided into 10 mixtures with 10 
odorants each, and tested on screening step two. Finally, on screening step three, individual 
odorants making up the mixture identified on step two were assessed and, ultimately, 
agonists/antagonists identified. Odorant mixtures were stored as stock solutions (all odours 
at 10 mM) and diluted just before use in Tyrode’s solution (see Appendix I: Media). 
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Before imaging experiments, D-MEM medium was replaced by Tyrode’s solution. Cells were 
then loaded with a cell-permeant Ca2+ indicator (7.5 µM Calcium Green-1 AM, 0.1% (w/v) 
Pluronic F-127, both sourced from Invitrogen, USA). Calcium Green-1 was chosen over other 
calcium indicators on the basis of its adequate Ca2+ affinity (dynamic range from 10nM to 40 
µM; Kd of 190 nM) and its relatively low cytotoxicity. Cells were incubated with the 
fluorescent dye for 45 min at 37 °C under 5% CO2 to allow for dye internalisation. Washing-
off of excess dye and ensuring remaining dye de-esterification before the start of the 
imaging experiment was achieved under standard perfusion with Tyrode’s (≈ 1 ml/min) for 
10 min at room temperature.  
Solutions were delivered through a RC-37 cell culture dish perfusion chamber insert (Harvard 
Apparatus, USA), fed by a gravity-driven eight-valve perfusion system (Harvard Apparatus, 
USA).  
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Figure 2.4 – Odorant screening strategy 
To identify active components in the Henkel 100 odorant library, the 100 odorant mixture has been subdivided into 
fractions with increasingly smaller numbers of odorants and these were sequentially tested for activity in single cell calcium 
imaging assays.  
 
Typical experiments consisted of 20 second applications of different odorant mixtures, 
diluted in Tyrode’s solution to 50 μM. Odorant applications were separated by 60 second 
periods in which cells were continuously perfused with Tyrode’s. HEK293 cells` physiological 
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state and their ability to produce PLC-mediated Ca2+ signals (Hansen et al., 1993) were 
monitored by application of 200 μM ATP (Sigma, UK) at the end of each experiment. 
Fluorescence recordings, indicating [Ca2+]i, were taken at room temperature (≈ 25 °C) under 
continuous perfusion using a Nikon TE300 inverted microscope illuminated with a blue LED – 
470 nm (CAIRN Research Ltd, UK). Images were acquired at 0.5 Hz 20X magnification using a 
Photometrics Quant-Em 512 CCD camera. Perfusion switching (Warner Instruments VC8 
valve controller), image acquisition and storage were controlled by a PC running MetaMorph 
acquisition software (Molecular Devices, USA). 
Data were processed offline using image analysis software (Image-Pro Analyser, Media 
Cybernetics, USA). Briefly, regions of interest (ROI) were drawn around single cells and mean 
intensity values extracted for each time point. All ROIs were individually assessed for correct 
placing around the cell at each time point and excluded from later analysis if cells had 
moved. As previously described (Kirkman-Brown et al., 2000), raw intensity values were 
exported to Microsoft Excel and normalized using the equation  
   
       
     
       
where R is normalized fluorescence intensity, F is fluorescence intensity at time t and Frest is 
the mean of 10 determinations of F taken during the control period. When looking at 
calcium responses evoked by odorant mixtures in HEK293 cells, responses were classed as 
positive only when the intensity change from baseline was at least 1/3 of that evoked by ATP 
for each individual cell. 
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2.3. Results 
2.3.1. Heterologous expression of OR2AE1 
Because olfactory receptor proteins, like all GPCRs, are structurally characterised by an 
extracellular N-terminus, and as described in 2.2.1, ORs featured on this work were 
expressed as N-terminal fusions with a short tag (FLAG) to allow for later receptor 
localisation and assess whether recombinant proteins were correctly localising to the plasma 
membrane. Figure 2.5 illustrates functional expression of OR2AE1 on HEK293 cells at plasma 
membrane level. As described in 2.2.2, cells were transfected with 2 µg of plasmid DNA 
(FLAG-OR2AE1) 24 hours after plating, fixed and immunostained with an anti-FLAG antibody 
to assess plasma membrane expression. Incubation with secondary FITC-conjugate anti-
mouse antibody revealed a sparse labelling pattern at the plasma membrane level, on 
5.6±1.1% of the cell population (Figure 2.5c), indicating a low level of functional expression 
of the receptor at the plasma membrane level. 
 
 
Figure 2.5 – Heterologous expression of OR2AE1 
HEK293 cells were transfected with 2 µg of plasmid DNA (FLAG-OR2AE1) 24 hours after plating and immunostained with an 
anti-FLAG antibody. Detection done by incubation with a secondary FITC-conjugate anti-mouse antibody and assessed by 
confocal microscopy at 40X magnification (a. Bright field; b. FITC fluorescence; c. Composite image = Bright field + FITC 
fluorescence). 
 
20 µm
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2.3.2. Odorant library screening – 50 odorant mixtures 
In line with the screening strategy adopted, and as described in 2.2.3, the initial screening 
step consisted of pinpointing activity to one of the two 50 odorant mixtures. HEK293 cells 
transfected with 2 µg of plasmid DNA were tested via single cell calcium imaging and 
percentages of responding cells for OR2AE1 or mock-transfected cells were compared 
(Figure 2.6). Responses on OR2AE1 transfected cells were notoriously higher for mixture A 
(0.9±0.5%) than for Mixture B (0.6±0.3%). Furthermore, there was a substantial difference 
between responses evoked in mock and receptor-transfected cells for mixture A, with levels 
in receptor-transfected cells (0.9±0.5%) being nearly four times higher than on mock-
transfected ones (0.2±0.2%). This, however, was not the case for mixture B, where mock-
transfected cells show a higher level of positives (0.8±0.4%) than receptor-transfected ones 
(0.6±0.3%), with the difference between them being a lot lower than the one observed for 
mixture A. Despite statistical analysis revealing no significant differences between the mean 
values described above (paired T test, t(40), P > 0.05), data points towards a higher level of 
responses in receptor-transfected cells when these were exposed to odorant mixture A. 
Although pointing towards activity in mixture A, the initial screening step for OR2Y1 did not 
comprise sufficient number of replicate experiments to allow for a comprehensive decision 
on which of the 50 odorant mixtures should be tested on further screening steps. 
Investigations for this receptor were abandoned at this stage due to lack of time to complete 
further odorant screening experiments necessary and therefore data is presented as 
preliminary in appendix (please see Appendix II: Supplementary Data, Supp. Figure 1) 
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Figure 2.6 – Calcium responses to mixtures A and B 
Mixtures include 50 odorants each at 50 µM. HEK293 cells were transfected with 2 µg of plasmid DNA (OR2AE1 or mock) 24 
hours after plating and labelled with 7.5 µM Ca2+ Green-1 24 hours after transfection. Single cell calcium imaging readings 
taken at 2 s intervals and processed data, plotted as percentage of responding cells ± SEM, consists of 21 experiments, each 
including an average of 250 cells. Differences between mean values of receptor and mock transfected cells responding are 
not statistically significant (Paired T test, t(20), P > 0.05) 
 
 
2.3.3. Odorant library screening – 10 odorant mixtures 
The next step involved screening mixtures D to H, 10 odorants each (Figure 2.7, Figure 2.8). 
As described above (2.2.3), and taking in to account the relatively high level of unspecific 
responses observed with the 50 odorant mixtures, a refinement of the technique was 
introduced, whereby in each experiment cells would be exposed to two consecutive 
applications of each odorant mixture (see second step, 2.2.4). This approach allowed for 
further discrimination between cell populations in each experiment in terms of resolution of 
calcium responses. This is based on the assumption that if a given cell responds to both 
applications of a particular odorant mixture (re-evoked response), this is more likely to be a 
specific response to the components of that mixture than if a cell responds to only one of 
the applications. When looking at total responses (percentage of cells within the observed 
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population that respond to either of the two applications of any given mixture) evoked on 
receptor-transfected cells, and although differences between means proved non-significant 
(paired T test, t(40), P > 0.05), mixtures F (2.3±1.8%) and G (1.7±1.2%) stand out from the rest, 
with levels of responses being higher (more than 4 fold) than the ones evoked by any of the 
other mixtures (Figure 2.7).  
 
Figure 2.7 – Total calcium responses to mixtures D to H 
Mixtures include 10 odorants each at 50 µM. HEK293 cells were transfected with 2 µg of plasmid DNA (OR2AE1 or mock) 24 
hours after plating and labelled with 7.5 µM Ca
2+
 Green-1 24 hours after transfection. Single cell calcium imaging readings 
taken at 2 s intervals and processed data, plotted as percentage of responding cells ± SEM, consists of 41experiments, each 
including an average of 250 cells. Differences between mean values of receptor and mock transfected cells responding are 
not statistically significant (paired T test, t(40), P > 0.05). 
 
However, when looking at levels of cells that respond to both applications of presented 
mixtures (re-evoked responses, Figure 2.8), it is obvious that, although overall level of 
responses is about one order of magnitude lower than the one observed for total responses 
(Figure 2.7), the ratio between specific (triggered on receptor-transfected cells) and 
unspecific responses (triggered on mock-transfected cells) is a lot higher, indicative of a 
better resolution between cells that functionally express the receptor and cells that don’t. By 
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analysing the data set in this way, mixture G (0.4±0.2%) alone stands out, being the only 
mixture triggering significantly more responses in OR2AE1 transfected cells than in mock 
transfected ones (paired samples T test, t(40) = 2.24, P < 0.031).  
Again, as the second screening step for OR2Y1 for the 10-odorant sub-mixtures included in 
mixture A did not result in conclusive data, probably due to an insufficient number of 
replicate experiments, a comprehensive decision on which of the 10 odorant mixtures 
should be tested in the following screening step could not be made, and data is therefore 
presented as preliminary (please see Appendix II: Supplementary Data, Supp. Figure 2). 
 
Figure 2.8 – Re-evoked calcium responses to mixtures D to H 
Mixtures include 10 odorants each at 50 µM. HEK293 cells were transfected with 2 µg of plasmid DNA (OR2AE1 or mock) 24 
hours after plating and labelled with 7.5 µM Ca2+ Green-1 24 hours after transfection. Single cell calcium imaging readings 
taken at 2 s intervals and processed data, plotted as percentage of responding cells ± SEM, consists of 41 experiments, each 
including an average of 250 cells; * indicates significant difference between responses in OR2AE1 and mock transfected 
cells (paired samples T test, t(40) = 2.24, P < 0.031). 
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2.3.4. Odorant library screening – individual odorants 
The second screening step identified mixture G as the one to be tested in the final screening 
step, and as discussed below (2.4), this involved identifying which of the individual 
components of mixture G was responsible for the increased excitability observed. Exposure 
of OR2AE1-transfected cells to the odorants making up mixture G has ultimately revealed 
ethyl 3,5,5-trimethylhexanoate, hereafter designated as Ω, as the agonist for the receptor in 
study ().  
 
 
Figure 2.9 – Re-evoked calcium responses to individual odorants in mixture G 
Odorants presented at 50 µM. HEK293 cells were transfected with 2 µg of plasmid DNA (OR2AE1 or mock) 24 hours after 
plating and labelled with 7.5 µM Ca2+ Green-1 24 hours after transfection. Single cell calcium imaging readings taken at 2 s 
intervals and processed data, plotted as percentage of responding cells ± SEM, consists of 3 experiments, each including an 
average of 300 cells; Differences between mean values of receptor and mock transfected cells responding are not 
statistically significant (paired T test, t(2), P > 0.05) 
 
This odorant triggered re-evocable responses in 3.0±2.8% of receptor-transfected cells and 
caused negligible stimulation (0.1±0.1%) in mock-transfected cells. Similar to what was 
observed for G1-G4, and when compared with stimulation levels caused by Ω, the remainder 
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odorants in mixture G (G6-G10) also failed to induce noticeable levels of responses in both 
mock and receptor-transfected cells. 
 
2.4. Discussion 
Olfactory receptors, together with a huge array of other GPCRs, have had huge interest from 
the scientific community as potential pharmacological targets. Particularly in olfaction, 
substantial research effort has been directed to identify ligand-receptor pairs, to which a 
major roadblock preventing further and more expedite advances has been the absence of an 
adequate heterologous expression system allowing good functional expression levels for 
ORs. Mainly because heterologous cells lack some of the specific molecular machinery used 
by native cells to correctly process and translocate these receptors to the plasma 
membrane, levels of functional expression in heterologous systems tend to be very low 
(Gimelbrant et al., 2001; Lu et al., 2003; McClintock et al., 1997). Adding to this shortfall, 
ORs, like other GPCRs, are known to undergo a desensitisation process (Gainetdinov et al., 
2004), where proteins expressed at plasma membrane are internalised via a clathrin-
dependant pathway after ligand binding (Jacquier et al., 2006; Mashukova et al., 2006; 
Rankin et al., 1999). In addition, single-molecule OR trafficking work revealed that in fact 
these receptors could also undergo constitutive internalisation even in the absence of ligand 
(Jacquier et al., 2006), through a process of continuous recycling of receptor molecules 
present at plasma membrane level. This, however, is not an absolute limitation for studying 
ORs in heterologous systems: data obtained using HEK293 cells as expression system, 
although made up of low levels of responses reflecting the low levels of functional 
expression, proved unequivocal in differentiating between mock and receptor-transfected 
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cells, therefore allowing adequate screening of the odorant library for OR2AE1 agonists. The 
low levels of responses observed, however, meant that the number of individual cells 
observed had to be maximized in order to increase the chance of including cells functionally 
expressing the OR in each observation. As reviewed by Mombaerts, 2004, this combination 
of calcium imaging and heterologous expression on HEK293 cells has been used before to 
successfully identify olfactory receptor – agonist / antagonist pairs in mouse and rat (Gaillard 
et al., 2002; Kajiya et al., 2001; Krautwurst et al., 1998; Oka et al., 2004), but more 
importantly also in human (Neuhaus et al., 2006; Spehr et al., 2003; Wetzel et al., 1999). 
Pervious success stories and relative resemblance of HEK293 cells with neurons (Shaw et al., 
2002) determined the choice of this system to study ORs featured in this project. 
In line with the pre-defined screening strategy to identify ligands for the olfactory receptors 
in this study, and looking at OR2AE1 in particular, the initial screening of the 50 odorant 
mixtures (Figure 2.6) pinpointed activity to mixture A. As expected, levels of responses in 
receptor-transfected cells to both mixtures tested were low. Mixture A evoked a higher level 
of responses in OR2AE1 transfected cells than mixture B, although this difference was not 
enough to take as an indication of what odorant subset to screen next. However, by taking 
into account the level of responses triggered by those mixtures in mock-transfected cells 
(responses to mix B twice as frequent than responses to mix A), the decision on further 
screening mix A components was substantiated both by a lower level of responses in mock-
transfected cells and also a higher level of responses in receptor-transfected cells. At this 
point of the screening, and because of the relatively complex nature of the stimuli involved, 
a complex response pattern was also expected – mixtures tested were made up of 50 
distinct odorants, each one with its own chemical identity. It’s not unreasonable to assume 
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that these mixtures could potentially activate distinct cellular responses via the cells’ set of 
native receptors, therefore explaining the differences observed for different mixtures in 
mock-transfected cells. Furthermore, it has recently come to light that a small group of 
natural and synthetic odorants, commonly used by the fragrance industry, can have a dual 
activity by activating both ORs at the plasma membrane as well as the nuclear estrogen 
receptor α (αER) in OSNs (Pick et al., 2009). Although any potential effects mediated by αER 
on HEK293s would hardly fall within the time frame of odorant screening experiments 
featured in this work, future work should consider including transcription / translation 
blockers to minimise possible interaction between OR and αER signaling cascades. On the 
other hand, reports about rapid non-genomic actions of estrogens in various cell types are 
abundant, together with evidence favouring the existence of plasma membrane receptors 
for 17β-estradiol (Stratton et al., 2010), and therefore the possibility of these mediating 
calcium signaling events triggered by odorants present in the mixtures tested should not be 
discarded. None of possible interactions mentioned above has been investigated in detail, as 
such investigations would fall out of the scope of the current work. 
Following on the results obtained for the initial step of the screening process, the second 
step consisted of testing components of mixture A for their capacity to evoke calcium signals 
in receptor-transfected cells. This was done by subdividing the 50 odorant subset into 5 
mixtures of 10 odorants each (mixtures D to H, Figure 2.7, Figure 2.8). At this stage however, 
and because as discussed above results for the 50 odorant mixtures showed relatively high 
levels of unspecific responses in mock-transfected cells, the experiment design was changed 
to allow for two consecutive applications of each mixture. This approach was based on the 
assumption that if a given cell responds to both applications of the same odorant mixture, 
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this is more likely to be an OR-mediated response than if a cell responds to only one of the 
applications. By looking at number of cells that respond to both applications of the same 
odorant mixture (re-evoked calcium responses - Figure 2.8) as opposed to total number of 
responses to either the first or second applications (total calcium responses - Figure 2.7), it 
becomes evident that, although the number of events recorded are substantially lower for 
re-evoked responses, the difference between events observed on receptor and mock-
transfected cells is much higher, indicating better resolution between specific events, 
mediated by OR2AE1 expressed at the plasma membrane in receptor-transfected cells, and 
unspecific responses, unrelated to the olfactory receptor, in mock-transfected cells.  
As such, and substantiated by re-evoked responses triggered by mixture G in OR2AE1-
transfected cells being at least three times higher than any of the other 10 odorant mixtures 
tested, the final screening step consisted on testing individual odorants making up mixture 
G. As evidenced in , only one of the odorants present in mixture G was able to evoke a 
noticeable level of responses in cells expressing the receptor, therefore revealing Ω as a 
strong agonist for OR2AE1.  
Interestingly, the level of re-evoked responses in receptor-transfected cells evoked by Ω was 
substantially higher (about one order of magnitude) than responses observed for mixture G, 
pointing towards the presence of an inhibitory effect within mixture G. This could possibly 
relate to a direct competition for the receptor’s binding site by one or more odorants in the 
mixture, if we accept the “lock-and-key” model to explain the molecular recognition 
between odorant and receptor molecules, or to the existence of one or more odorants in the 
mixture with the same vibrational profile, if we assume the vibrational model.  
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Overall, the screening strategy adopted, in conjunction with use of HEK293 cells as an 
expression system, allowed for good resolution of responses, despite the small numbers 
observed. This system, although demanding considerable number of repetitions due to the 
low levels of functional expression, has ultimately delivered a strong agonist for OR2AE1, 
which was subsequently tested in human sperm (see chapter 3). 
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3. FUNCTIONAL INVESTIGATION OF OR2AE1 IN 
HUMAN SPERMATOZOA 
3.1. Introduction 
It has long been observed that a substantial subset of the OR gene pool is not restricted to 
olfactory organs, also being expressed ectopically in a variety of other tissues, with particular 
incidence in the male reproductive system, including testis and male germ cell line (Asai et 
al., 1996; Goto et al., 2001; Linardopoulou et al., 2001; Parmentier et al., 1992; Spehr et al., 
2003; Vanderhaeghen et al., 1997a; Vanderhaeghen et al., 1997b; Volz et al., 2003). 
Interestingly, OR expression has also been reported in mature sperm of several mammalian 
species (Baker et al., 2007; Lefievre et al., 2007; Parmentier et al., 1992; Spehr et al., 2004; 
Vanderhaeghen et al., 1993; Vanderhaeghen et al., 1997b). The big question arising from OR 
expression in mammalian sperm is whether these proteins play a role in reproduction or if 
their presence in sperm is only a stroke of chance. Recent microarray work looking at OR 
expression in non-olfactory tissues (De la Cruz et al., 2009) reveals that ectopic expression of 
OR orthologous genes in human and chimpanzee co-localise in the same non-olfactory 
tissues more frequently than expected by chance alone. Importantly this work also exposes a 
stronger evolutionary constraint for the ectopically expressed OR subset when compared to 
genes expressed in the olfactory epithelium alone, which is certainly consistent with the 
notion that these genes have additional functions in non-olfactory tissues.  
The proposal of such functions for ectopically expressed ORs was first published in a 
landmark paper by Marc Spehr and colleagues (Spehr et al., 2003). This work matched a 
testicular OR (OR1D2, also known as hOR17-4), later found to be present also in mature 
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human sperm (Spehr et al., 2004), to its agonist odorant bourgeonal, but most importantly, 
this work showed that this small aldehyde molecule triggers a robust Ca2+ signal in human 
sperm, resulting in a positive chemotactic response towards the odorant. Shortly after, 
Fukuda et al., 2004 have also linked a mouse testicular OR (Olfr16, also known as mOR23) 
and activating odorant lyral, to a similar chemotactic effect and corresponding increase in 
calcium signaling on mouse spermatozoa. More recently, and following on Spehr’s previous 
work, Veitinger et al., 2011 have further matched two human testicular ORs (OR7A5 and 
OR4D1) to their activating molecules (myrac aldehyde and PI-23472, respectively), and 
characterised specific calcium signaling events evoked by these molecules, associating them 
with distinct stimulus-specific motility patterns in human sperm. Although based on sperm 
behaviour observations made in in vitro conditions– which, as reviewed by Gaffney et al., 
2011, are far from correctly modelling the environment spermatozoa find in vivo – evidence 
on the mentioned chemotactic and chemokinetic effects observed strongly suggests that 
OR-controlled sperm guidance and swimming behaviour could be present within the 
mammalian female reproductive tract and play an important role in reproduction. The fact 
that sperm display the appropriate molecular tools for OR signal transduction (Baxendale 
and Fraser, 2003 Spehr et al., 2004) further substantiates this possibility. 
Following on the characterization of OR2AE1 in the heterologous expression system and 
matching of the receptor with its newly found agonist (see section 2), the experimental work 
within this chapter aimed to investigate and characterise potential physiological effects of Ω 
in mature human sperm. 
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3.2. Material and Methods 
3.2.1. Sperm preparation / capacitation 
Sperm samples were obtained from a panel of volunteer healthy donors recruited at the 
Birmingham Women’s Hospital (HFEA centre 0119) in accordance with the Human 
Fertilisation and Embryology Authority (HFEA) Code of Practice. Ejaculates were obtained by 
masturbation and semen allowed to liquefy for 30 minutes. As described by Mortimer, 1994, 
and depending on whether further experiments required capacitated or uncapacitated cells, 
motile spermatozoa were then isolated by swim-up into either capacitating (sEBSS - 
supplemented Earl’s Balanced Salt Solution) or non-capacitating (Tyrode) medium (Appendix 
I: Media). Briefly, 1 ml of media was under-layered with 0.3 ml of semen in 4 ml round-
bottomed tubes (Falcon 2054) and set-up was incubated for one hour at 37: C 6% CO2. The 
motile fraction was then recovered from the top layer of the swim-up set-up and cell 
concentration assessed and adjusted to 6x106 cells/ml. For capacitating conditions, sperm 
were further incubated for 4 hours at 37: C 6% CO2 to allow capacitation to occur. 
 
3.2.2. Single cell calcium imaging  
Capacitated sperm cell suspensions (see 3.2.1) were split into 200 µL aliquots (6x106 
cells/ml) and incubated in labelling solution (7.5 µM Calcium Green-1 AM (Invitrogen, USA) 
0.1% (w/v) Pluronic F-127 (Invitrogen, USA) in sEBSS) for 45 minutes at 37: C 6% CO2. Cell 
suspensions were washed from the labelling media (300 RCF, 7.5 minutes), pellet re-
suspended in dye-free sEBSS and cells left to rest for at least 10 minutes (37: C 6% CO2) to 
allow for washing-off of excess dye and completion of any remaining dye de-esterification 
before the start of the experiment. An aliquot (110 µL) of the cell suspension was then 
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loaded into a purpose-built perfusable imaging chamber where the lower glass coverslip had 
previously been coated with 0.1% Poly-D-lysine (BD, USA). The loaded imaging chamber was 
incubated at 37: C 6% CO2 for a further 10 minutes, to allow cells to attach to the Poly-D-
Lysine-coated surface, and then linked to a gravity-driven eight-valve perfusion system 
(Harvard Apparatus, USA) adjusted to a 1 ml/min flow rate.  
In standard single-cell calcium imaging experiments, cells were kept under continuous sEBSS 
perfusion, allowing for an initial 10 minute control period before any test solution being 
presented. Stock solutions of the different odorants tested were initially prepared in 
dimethyl sulfoxide (DMSO) and dispersed in sEBSS on the day of the experiment to their final 
working concentration ([DMSO] < 0.001%). Odorants were delivered as four sequential 20 
seconds applications interleaved with 5 minute rest periods, where cells were perfused with 
sEBSS alone, and 3.2 µM progesterone was applied at the end of each experiment to assess 
cell’s capacity to develop calcium transients. Fluorescence recordings, indicating [Ca2+]i, were 
taken at room temperature (≈ 25° C) using an inverted microscope (Nikon TE300) illuminated 
with a blue LED – 488 nm (CAIRN Research Ltd, Kent, UK). Images were acquired at 40X 
magnification using a CCD camera (Quant-Em 512 – Photometrics, USA) running at 0.4 Hz. 
Perfusion switching (Warner Instruments VC8 valve controller), data acquisition and storage 
were controlled by a PC running MetaMorph acquisition software (Molecular Devices, USA). 
Data were processed offline using image analysis software (Image-Pro Analyser, Media 
Cybernetics, MD, USA). Briefly, a single region of interest (ROI) was drawn for each sperm 
cell (to include head and midpiece) and mean intensity values were extracted for each time 
point. All ROIs were individually assessed for correct placing around the cell at each time 
point and excluded from later analysis if cells had moved. As previously described (Kirkman-
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Brown et al., 2000), raw intensity values were exported to Microsoft Excel and normalized 
using the equation  
   
       
     
       
where R is normalized fluorescence intensity, F is fluorescence intensity at time t and Frest is 
the mean of 20 determinations of F taken during the control period (rest period before first 
application of agonist). A cell was considered to have developed a measurable calcium 
transient if the condition  
                             
was satisfied, where Mp is the arithmetic mean of the five highest values within the 50 
seconds period immediately after odorant application, Mc is the arithmetic mean of the five 
highest values within the 50 seconds period immediately before odorant application, and 
CI98% is the mean’s 98% confidence interval (α = 0.02, normal distribution), indicating the 
reliability of the estimate. This approach to identify calcium transients is a minor variation of 
the previously described method (Kirkman-Brown et al., 2000) and results from an 
adaptation of the former to this work’s experimental conditions.  
For the high-speed single-cell calcium imaging experiments, designed to investigate sub-
cellular onset of Ω-evoked calcium signals, cells were prepared / capacitated as described 
(3.2.1) and, unless otherwise stated, set-up was identical to standard experiment described 
above. Cells were exposed to a single 20 second application of 50 µM Ω and florescence 
recordings were taken at 60X magnification for 70 seconds from agonist application, at 12.5 
Hz. Response delays for individual cells were defined as the time (s) between Ω application 
(start of fluorescence recording – T0) and the time point where average fluorescence 
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variation from control period (20 time points from T0) exceeded 30% of the amplitude of the 
corresponding peak. 
For experiments aiming to elucidate which pathways are involved in the transduction of the 
Ω-evoked calcium signal, set-up was the same as described above for the standard single-cell 
calcium imaging experiment. Inhibitors tested were: 10 µM SQ 22536 (mAC inhibitor – cAMP 
pathway), 25 µM cAMPS-Rp (cAMP analogue that acts as a competitive antagonist of the 
cAMP-induced activation of PKA – cAMP pathway), 5 µM U 73122 (PLC inhibitor – IP3 
pathway) and 10 µM NNC 55-0396 (T-type calcium channel blocker). As described above for 
the standard experiment, cells were exposed to four 20 seconds applications of Ω at 50 µM, 
but in this case the time lapse included an extra 10 minutes perfusion period between the 
second and third applications of Ω, where cells were exposed to the appropriate 
concentration of the various inhibitors tested, and also, the third application of Ω was done 
in presence of inhibitor. Inhibition was defined as the ratio of cells that, responding to Ω 
applications 2 and 4, did not respond to application of Ω together with inhibitor. 
 
3.2.3. Chemotaxis assay 
In order to probe odorant molecules for potential chemotactic effects, a simple 
experimental design similar to the sperm accumulation in a capillary assay described by Ralt 
et al., 1994, was applied whereby aliquots of motile spermatozoa suspension (3.2.1) were 
exposed to either Ω (5, 50 or 500 µM; 0.01, 0.001 or 0.0001% DMSO respectively), 
bourgeonal (5, 50 or 500 µM; 0.01, 0.001 or 0.0001% DMSO respectively) or sEBSS + 0.01, 
0.001 or 0.0001% DMSO (as control solutions for 5, 50 or 500 µM odorant concentrations, 
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respectively). Briefly, spermatozoa pre-labelled with 3 µg/ml Hoechst 33342 (Invitrogen, 
USA) were divided into 12 20 µL aliquots in 0.2 ml reaction tubes. 
 
Figure 3.1 – Chemotaxis assay set-up 
 
A multi-channel micro pipette was loaded with the different test solutions and controls (20 
µL in each pipette tip) and tips dipped into the 20 µL sperm suspensions (Figure 3.1).  
The gradient formation for the different odorant concentrations (Figure 3.2) was calculated 
according to the formula 
   
  
 
 
where T is time (seconds), L is length (cm) and D is diffusion coefficient (cm2/s). The formula 
describes diffusion of a chemical in a still fluid, from a 'blob' source which has constant 
chemical concentration, and calculations assume a constant diffusion coefficient of 5.7x10-6 
cm2/s, calculated according to Hayduk-Laudie method (Hayduk and Laudie, 1974), 
appropriate for modelling diffusion of low charge molecules in aqueous solutions.  
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Figure 3.2 – Gradient formation in chemotaxis assay set-up for different odorant concentrations 
Gradient formation for A. 5 µM, B. 50 µM and C. 500 µM concentrations of Ω and bourgeonal. 
 
A
B
C
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Different solutions (odorants and controls) were tested in duplicate and set-up was 
incubated for one hour at 37: C 6% CO2. Individual volumes in the pipette tips were then 
transferred to a clean 0.2 ml tube, incubated at 65: C for 10 minutes and centrifuged at 4000 
RCF for 10 minutes. Supernatant was discarded and cell pellet re-suspended in 10 µL H2O 
and loaded into 20 µm CASA slides (Leja, Netherlands). The whole volume on the CASA slide 
was scanned at 10X magnification on a Nikon TE300, coupled to a CCD camera (Quant-Em 
512 – Photometrics, USA) and illuminated with a UV LED – 365 nm (CAIRN Research Ltd, 
Kent, UK). Fluorescently labelled cells were scored offline on a PC running MetaMorph 
imaging software (Molecular Devices, USA). 
 
3.2.4. Acrosome reaction 
For the assessment of Ω-induced acrosome reaction, cells were prepared / capacitated as 
described in section 3.2.1. After capacitation period, sperm suspension was centrifuged at 
300 RCF for 7 minutes (2X) and cell pellet re-suspended in phosphate buffered saline (PBS) 
to remove any excess BSA. Cell suspension was adjusted to 6X106 cells/ml and divided into 
100 µL aliquots. Spermatozoa were stimulated with either Ω (5, 50 or 500 µM; 0.01, 0.001 or 
0.0001% DMSO respectively), calcium ionophore (10 µM A23187 – positive control) or sEBSS 
+ 0.01, 0.001 or 0.0001% DMSO (as negative control for 5, 50 and 500 µM Ω, respectively). 
The reaction mixtures were incubated for one hour at 37: C 6% CO2 and 3 µM propidium 
iodide was added 10 minutes before the end of the incubation period to distinguish non-
viable spermatozoa. Mixtures were then centrifuged at 300 RCF for 7 minutes and cell 
pellets re-suspended in 40 µL PBS. Cells were smeared onto microscope slides pre-coated 
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with 20 µg/ml poly-L-lysine and air-dried. Smears were then permeabilised in 100% 
methanol for one minute, air-dried and stained with 1 µg/ml FITC-PSA (Sigma-Aldrich, USA) 
for one hour at 37: C. Slides were washed three times with PBS, air-dried and mounted using 
Fluoromount (Sigma-Aldrich, USA). Slides were left overnight at 4: C for mounting to set, and 
acrosome reaction scored under fluorescent microscopy as described by (Mendoza et al., 
1992). Each result is an average of 2 replicate slides, with >200 cells being scored in each 
slide, and Ω-induced AR was expressed as AR stimulation, according to the formula 
        
   
   
      
where R is the percentage of acrosome reacted spermatozoa (AR) in the test mixture, C is 
percentage AR in control mixture and I is the percentage AR in suspension treated with 
calcium ionophore A23187. 
 
3.2.5. Migration assay 
Effect of Ω on sperm migration was investigated using a modified Kremer test (hyaluronate 
migration test – HMT) (Kremer, 1965). Briefly, 50 x 4 x 0.4 mm glass capillary tubes (CM 
Scientific, UK) were filled by capillary action with 1% methylcellulose (4000cp viscosity on a 
2% solution at 20°C – Sigma-Aldrich, UK) made up in sEBSS, sealed at one end with Cristaseal 
(Hawksley, UK) and equilibrated at 37: C 6% CO2 on a humidified chamber. Fresh semen 
samples were allowed to liquefy at room temperature for 30 minutes, divided into 50 µL 
aliquots in BEEM capsules (Biopoint, UK) and treated in duplicate with either 50 µM Ω or 
sEBSS + 0.001% DMSO. The capillaries were then lowered into each BEEM capsule and test 
was incubated at 37: C 6% CO2 for one hour, after which number of spermatozoa at 1, 2, 3 
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and 4cm migration distances (total of four fields of view per distance) were assessed 
microscopically using a 20X phase contrast objective.  
 
3.2.6. Motility 
Computer assisted semen analysis (CASA) was used in order to investigate the effects of Ω in 
sperm motility. Sperm suspensions were prepared as described in section 3.2.1, treated 
either with 50 µM Ω (0.001% DMSO) or sEBSS + 0.001% DMSO, and loaded into 50 µm depth 
CASA slides (Conception Technologies, USA). Motility parameters were assessed at times 0, 
5, 15, 30 and 60 minutes after exposure to the test solution by CASA (Hamilton Thorne, 
USA). Cells were considered to exhibit hyperactivated motility if their track speed (VCL) was 
> 150 µm/s, their linearity (LIN) was < 50% and their lateral head displacement (ALH) was 
either > 5 µm (cells classed as sort 5) or > 7 µm (cells classed as sort 7). 
 
3.3. Results 
3.3.1. Ω evokes Ca2+ signaling events in human spermatozoa 
Based on firm proteomics evidence substantiating ectopic expression of OR2AE1 in mature 
human sperm (Baker et al., 2007; Lefievre et al., 2007), investigations of potential functional 
roles this particular receptor might play on these cells was started by assessing whether, 
similarly to what was observed in the heterologous expression system, its newly found 
agonist Ω (see section 2) would also trigger Ca2+-mediated signaling events in human sperm. 
Figure 3.3 illustrates a typical single-cell Ca2+ imaging experiment in which, as described in 
section 3.2.2, sperm cells were sequentially exposed to four 20 second applications of 50 µM 
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Ω. In this particular example, one of the cells (cell 15) shows no noticeable variation in 
fluorescence after all Ω applications, whilst still capable of generating calcium signals as 
evidenced by response to 3.2 µM progesterone. Contrastingly, cell 254 responds to three of 
the four 50 µM Ω applications (App 2, 3 and 4), with fluorescence increases of around 25-
30%.  
 
 
Figure 3.3 – Ca
2+
 responses to sequential applications of 50 µM Ω 
Typical [Ca
2+
]i recording: traces show normalized fluorescence plot for 2 sperm cells labelled with 7.5µM Ca
2+
 Green and 
perfused 4 x 20s with 50μM Ω. 3.2μM progesterone applied at the end of the experiment to verify physiological state and 
ability to generate Ca
2+
 signals. 
 
As 50 µM Ω caused measurable Ca2+ transients in sperm, the next set of experiments aimed 
to preliminarily delimit an effective concentration range of the OR agonist capable of 
triggering the observed signaling events.  
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Figure 3.4 – Dose-response curve for Ca
2+
 responses evoked in mature sperm by Ω 
Sperm cells were allowed to capacitate for 5 hours, labelled with 7.5µM Ca
2+
 Green and exposed to 20s applications of 
increasing Ω concentrations (5x10
-8
, 5x10
-7
, 5x10
-6
, 5x10
-5
and 5x10
-4
 M). Data, plotted as percentage of responding cells ± 
SEM, consists of 4 experiments, each including an average of 280 cells. Best-fit values derived from variable curve fitting 
model, with a Hill coefficient of 1.2. 
 
 
Exposure of sperm to increasing Ω concentrations resulted in an increase in the number of 
cells initiating calcium signals (Figure 3.4). The percentage of the cell population responding 
to Ω increases from 1.9±0.5% for 50 nM, to 33.6±4.3% for 500 µM. This increase was more 
evident between 500 nM and 5 µM (11.5%) and between 5 µM and 50 µM (16.1%), with the 
nonlinear variable curve fitting resulting in a typical sigmoidal shaped curve (R2 = 0.842, df = 
26) with an EC50 of 6.2X10
-6 M and a Hill coefficient of 1.2. 
 
3.3.2. Variability of Ω-evoked signaling  
Further testing of 50 µM Ω across different donors revealed a substantial degree of 
variability in the percentage of cells responding to the agonist, both within and across 
donors (Figure 3.5). Amplitude in the percentage of cells responding to the third application 
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of agonist within sperm donors ranged from 6.6% for D700, to 32.2% for D600. Pooled 
results ranged from a minimum of 9.4% to a maximum of 46.6%, with a median value of 
21.2%.  
 
 
Figure 3.5 – Variability of Ω-evoked Ca
2+
 responses in capacitated sperm from different donors 
Sperm cells were allowed to capacitate for 5 hours, labelled with 7.5µM Ca
2+
 Green and exposed to four sequential 
applications of 50 µM Ω, each lasting 20s. Ω applications were intercalated with 5 minute rest periods where cells were 
perfused with media alone. Data consists of 27 experiments across 6 donors, each including an average of 280 cells. 
Boxplots show response distribution to the third application of Ω within individuals (individual donors, in orange) and within 
donor population (pooled results for all donors, in green); whiskers represent minimum and maximum percentage cells 
responding to agonist. 
 
Experimental data gathered to this stage pointed to a complex response pattern within the 
sperm cell population, with some cells developing Ω-dependant calcium transients from the 
first exposure to the agonist, and others only responding to Ω after one or more previous 
applications. A subset of experiments were conducted to further investigate this variability. 
As described in section 3.2.2, capacitated spermatozoa were exposed to four 20 second 
applications of 50 µM Ω, intercalated with 5 minute rest periods, where cells were 
maintained under continuous perfusion with sEBSS. The average percentage of cells 
developing calcium transients in response to agonist exposure increases from 11.7±1.8% for 
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App 1, to 29.1±4.5% for App 4 (Figure 3.6). The percentage of cells responding to second, 
third and fourth applications was found to be significantly higher than cells responding to 
the first application (one-way ANOVA, F(1,11) = 9.822, p<0.01), indicating that the first 
exposure to Ω has a priming effect on the cells’ responsiveness to the odorant. 
 
 
 
Figure 3.6 – Distribution of human sperm population responding to successive applications of 50 µM Ω 
Sperm cells were allowed to capacitate for 5 hours, labelled with 7.5µM Ca
2+
 Green and exposed to four sequential 
applications of 50 µM Ω, each lasting 20s. Ω applications were intercalated with 5 minute rest periods where cells were 
perfused with media alone. Data, plotted as percentage of responding cells ± SEM, consists of 13 experiments, each 
including an average of 290 cells. * indicates significant difference between groups (one-way ANOVA, F(1,11) = 9.822, 
p<0.01). 
 
3.3.3. Ω-evoked Ca2+ signaling in sperm is capacitation dependent 
Another indication arising from preliminary experiments testing Ω’s ability to evoke calcium 
signaling in sperm was that this effect appeared to be dependent on the time cells were 
allowed to capacitate. Results for percentage of cells responding to the third application of Ω 
(results collected from 36 experiments with identical format – four sequential agonist 
applications spaced by 5 minute rest intervals) were compiled and analysis of the association 
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between capacitation time and the percentage of cells responding to Ω shows a high positive 
correlation between both variables (Figure 3.7), illustrated by the two-tailed Pearson’s 
correlation coefficient (r=0.57, p<0.0003).  
 
 
Figure 3.7 – Association between Ca
2+
 responses evoked by Ω in mature sperm and sperm cell capacitation 
Dashed line represents linear regression between capacitation time and percentage of cells responding to third application 
of 50 µM Ω (two-tailed Pearson’s correlation coefficient, r=0.57, p<0.0003). Data compiled from 36 experiments, each 
including an average of 250 cells. 
 
3.3.4. Ω triggers chemotactic responses in sperm 
Following on previous results revealing Ω as capable of eliciting signaling events in human 
sperm, the next step in this research involved investigating whether these events actually 
translated to any measurable changes in sperm cell function. To this end, an experimental 
method was designed to test odorant molecules for potential chemotactic effects in motile 
sperm (see section 3.2.3). Ω, an odorant molecule identified in the current work as capable 
of activating the olfactory receptor OR2AE1, was tested alongside bourgeonal, another 
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odorant previously reported to exhibit a potent chemotactic effect in human sperm (Spehr 
et al., 2003) (Figure 3.8). 
 
 
Figure 3.8 – Effect of Ω and bourgeonal in human sperm chemotaxis  
Chemotactic effect evoked by Ω and bourgeonal in motile sperm. Data, plotted as percentage variation from control ± SEM 
includes 13 replicates across 6 donors; * indicates significant difference between control and test stimuli (2-tailed Wilcoxon 
signed ranks test, Z=-3.110, p<0.02). 
 
5, 50 and 500 µM solutions of both odorants all caused a measurable increase in the number 
of cells in the pipette tip volume, but this increase was only significantly different from 
control (2-tailed Wilcoxon signed ranks test, Z=-3.110, p<0.02) for 50 µM Ω, with an average 
of 204.6±67.0% more cells travelling into the pipette volume than in control. Interestingly, 
for bourgeonal the chemotactic effect increases steadily with increasing concentrations 
(50.9±23.2, 78.7±39.1 and 94±64.9% for 5, 50 and 500 µM respectively), whereas for Ω this 
effect increases from 103±59% (for 5 µM) to 204.6±67% (for 50 µM) but for 500 µM Ω the 
chemotactic effect drops radically to 23.5±29.1%.  
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3.3.5. Effect of Ω on acrosome reaction 
Another sperm function investigated was the ability to undergo the acrosome reaction. As 
described in section 3.2.4, acrosome reaction was measured as AR stimulation, which 
excludes spontaneous AR in the cell population and indexes maximum stimulation to AR 
levels observed in cells exposed to calcium ionophore. Concentrations of 5, 50 and 500 µM Ω 
were tested for their ability to trigger the acrosome reaction in motile spermatozoa (Figure 
3.9). Both 5 and 50 µM Ω failed to cause a significant variation in the acrosome reaction rate 
(2-tailed Wilcoxon signed ranks test, Z=-1.992, p<0.046), with AR stimulations of 1.2±2.1% 
and 0.1±2.8% for 5 and 50 µM Ω respectively. However, when exposed to 500 µM Ω, sperm 
cells displayed a significantly higher acrosome reaction rate than control (Appendix II: 
Supplementary Data, Supp. Figure 3), as illustrated by a stimulation rate of 24.6±15.7%.  
 
 
Figure 3.9 – Effect of Ω on acrosome reaction 
Acrosome reaction triggered by 5, 50 and 500 µM Ω in mature human sperm. Data, plotted as percentage AR stimulation ± 
SEM, includes 6 experiments across 6 donors. * indicates a significant difference between control and test stimuli (2-tailed 
Wilcoxon signed ranks test, Z=-1.992, p<0.046). 
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3.3.6. Effect of Ω on sperm migration and motility 
The effect of Ω on sperm migration was also assessed (). As described in section 3.2.5, 
spermatozoa were exposed to 50 µM Ω and allowed one hour to travel up a microcapillary 
pre-filled with a 1% methylcellulose solution (modified Kremer test – Kremer, 1965). The 
choice of this assay was based on its approximation to the conditions sperm might 
encounter in vivo, with the solution’s viscosity closely mimicking that of cervical mucus, and 
on balance, the absence of a suitable positive control represented a minor caveat.  
 
 
Figure 3.10 – Effect of Ω on sperm migration 
Migration was scored for four distances along the capillary (1, 2, 3 and 4 cm, in green; sum of cells scored at all distances, in 
orange). Data, plotted as percentage variation from control ± SEM, consists of 6 experiments across 6 donors. 
 
The number of cells scored at 1, 2 and 3 cm was on average 28% higher for samples exposed 
to the odorant than in control, whereas at 4 cm there were 27% less cells than in control. 
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Overall, number of cells scored at all distances was 24% higher for samples exposed to 50 
µM Ω than for control samples, but these differences did not prove statistically significant 
(one-way ANOVA). 
Motility changes evoked by 50 µM Ω were also investigated by computer assisted sperm 
analysis (CASA). As described in section 3.2.6, motile cells were isolated and incubated in 
capacitating medium for 5 hours. Spermatozoa were then exposed to either control solution 
(sEBSS) or 50 µM Ω and their motility assessed at times 0, 5, 15, 30 and 60 minutes after 
exposure to the test solution (Figure 3.11). 
 
 
 
Figure 3.11 – Effects of Ω on sperm hyperactivation 
Motile sperm were exposed to 50 µM Ω and motility changes accessed by CASA at 0, 5, 15, 30 and 60 minutes. Data, 
plotted as percentage variation from control ± SEM, includes 7 experiments across 6 donors. Differences presented proved 
non-significant (one-way ANOVA, P > 0.053). 
 
The cell population exposed to Ω appear to include a higher ratio of sperm exhibiting 
hyperactive motility, as defined by CASA sorts 5 and 7 (see section 3.2.6). With the exception 
of time 5 min, for all the other times observed the level of hyperactive cells is higher in 
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populations exposed to the odorant than in cells treated with the control solution. This is 
particularly evident at time 30 min, where sort 7 and sort 5 are respectively 117±82% and 
72±38% higher in cells treated with Ω than in the control population. These differences, 
however, did not prove statistically significant (one-way ANOVA). Other motility parameters 
were also assessed by CASA on cells exposed to 50 µM Ω, but treatment did not cause 
significant changes when compared with control (Supp. Figure 4 and Supp. Table 1 - 
Appendix II: Supplementary Data). 
 
3.3.7. Characterisation of Ω-evoked Ca2+ signaling 
After characterising functional effects evoked by Ω in human sperm, and as described in 
section 3.2.2, a series of high speed single cell calcium imaging experiments was carried out 
aiming to gain an insight on the origin of the inherent Ca2+ signal within the sperm cell 
(Figure 3.12). Briefly, motile sperm cells were allowed to capacitate for 5 hours, exposed to a 
20 seconds application of 50 µM Ω and intracellular calcium levels monitored at 12.5 Hz for 
70 seconds. For each cell included in the analysis two areas of interest (AOIs) were drawn 
(one including the whole head and the other including the whole midpiece) and onset of the 
calcium signal was recorded. Delay observations in individual cells ranged from -2.88 s 
(signal initiated in the head and 2.88 seconds later propagated to the midpiece) to +9.36 s 
(signal initiated in the midpiece and 9.36 seconds later propagated to the head). Mean delay 
across cell population was +1.36±0.51 seconds, and a one-sample t test revealed a 
statistically reliable difference between the hypothetical delay of zero and the mean delay 
reported (t(30)=2.678, p<0.012).  
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Figure 3.12 – Subcellular onset of Ca
2+
responses triggered by 50 µM Ω in human spermatozoa 
Boxplot illustrates distribution of the Ca
2+
 response onset delay (s) across sperm head and midpiece. Data includes 31 cells 
and whiskers represent minimum and maximum values. * indicates a significant difference between the hypothetical delay 
of zero and the mean delay observed (one-sample t test, t(30)=2.678, p<0.012). 
 
 
Further to the investigation of the Ω-evoked calcium signal onset, a further set of single-cell 
calcium imaging experiments were performed, aiming to elucidate which pathways might be 
involved in the signal transduction observed. Briefly, and as described in section 3.2.2, a 
series of inhibitors of key players in pathways known to transduce calcium signals were 
tested. Motile fractions of the semen samples were isolated and incubated in capacitating 
medium for 5 hours. Cells were initially exposed to two applications of 50 µM Ω on its own 
and then perfused with appropriate concentration of inhibitor for 10 minutes. A third 
application of Ω was done in the presence of inhibitor, followed by a fourth application 
without inhibitor. As described in 3.2.2 (discussed below – section 3.4), inhibition was 
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defined as the ratio of cells that, responding to Ω applications 2 and 4, did not respond to 
application of Ω together with inhibitor. Inhibitors tested were: SQ 22536 (mAC inhibitor – 
cAMP pathway), cAMPS-Rp (cAMP analogue that acts as a competitive antagonist of the 
cAMP-induced activation of PKA – cAMP pathway), U 73122 (PLC inhibitor – IP3 pathway) 
and NNC 55-0396 (T-type calcium channel blocker) ().  
 
 
Figure 3.13 – Inhibition of calcium signaling events triggered by 50 µM Ω in human sperm  
Inhibitors tested were: SQ 22536 (100 µM), cAMPS-Rp (25 µM), U 73122 (5 µM) and NNC 55-0396 (10 µM). Sperm cells 
were allowed to capacitate for 5 hours, labelled with 7.5µM Ca
2+
 Green and exposed to three applications of odorant alone 
and one application of odorant + inhibitor. Data, plotted as percentage inhibition ± SEM (see section 3.2.2 for inhibition 
definition), consists of 7 (SQ 22536 100), 2 (cAMPS-Rp), 1 (U 73122) and 11 (NNC 55-0396) experiments, each including an 
average of 290 cells. 
 
Inhibitor concentrations used were chosen in line with published results by other groups 
where the inhibitor has been tested in human (NNC 55-0396 - Strunker et al., 2011; SQ 
22536 – Spehr et al., 2004; U 73122 – Bahat et al., 2010) or bovine sperm (cAMPS-Rp – 
Galantino-Homer et al., 1997). 
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Both inhibitors acting on the cAMP pathway (100 µM SQ 22536 and 25 µM cAMPS-Rp) were 
able to inhibit most of the cells from developing calcium transients in response to 50 µM Ω 
(66.3±11.1% and 72±14.9%, respectively). Interference on the IP3 pathway with 5 µM U 
73122 resulted in a much lower level of inhibition (11.7%), whereas,  blocking T-type calcium 
channels with 10 µM NNC 55-0396 caused the highest level of inhibition observed 
(77.6±3.2%). 
Importantly, all inhibitors tested had themselves effects on [Ca2+]i (Figure 3.14). The most 
dramatic effect was observed when spermatozoa were exposed to 10 µM NNC 55-0396: cells 
developed an almost instantaneous (10 seconds from application) Ca2+ transient, reflected 
by an increase in fluorescence peaking at around 40%. This transient lasted around 200 
seconds, and [Ca2+]i levels were maintained around 10% above baseline level after the 
transient for as long as the cells were exposed to the inhibitor. 5 µM U73122 had a similar 
effect, although the transient’s amplitude was lower (peaking at around 10% above 
baseline), slightly shorter (lasting around 150 seconds) and with a longer onset (20 seconds). 
In this case, however, [Ca2+]i levels after the transient tended to raise steadily, from 200 to 
600 seconds, to around 10% above baseline. Unlike the previous inhibitors, the rise in [Ca2+]i 
triggered by 25 µM cAMPS-Rp was not “transient-like”, rather a more or less continuous 
increase up to around 20% above baseline, with a slower onset (50 seconds). The effect of 
100 µM SQ22536 on [Ca2+]i was not as evident as for the other inhibitors tested, with 
majority of cells failing to develop Ca2+ transients and [Ca2+]i staying raised, but within 5% 
from base level.  
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Figure 3.14 – Ca
2+
 transients developed by human spermatozoa when exposed to different inhibitors 
Inhibitors tested were: SQ 22536 (100 µM), cAMPS-Rp (25 µM), U 73122 (5 µM) and NNC 55-0396 (10 µM). Sperm cells 
were allowed to capacitate for 5 hours, labelled with 7.5µM Ca
2+
 Green and exposed to inhibitor for 600 seconds under 
constant perfusion. Data collected from one representative experiment for each inhibitor and traces, normalised to the 
start of the application, represent average fluorescence variation from control period (see section 3.2.2) for the whole cell 
population monitored (average of 290 cells). 
 
 
 
Figure 3.15 is a particular example of a typical Ca2+ imaging experiment where the aim was 
to elucidate the pathways involved in the transduction of calcium signals elicited by Ω. This 
experiment tested the ability of T-type Ca2+ channel inhibitor NNC 55-0396 at 10 µM to 
inhibit Ω-evoked calcium transients. As described in section 3.2.2, cells were exposed to the 
agonist twice (Ω_1 and Ω_2, for 20 seconds each, intercalated with a 4 minute rest period 
where cells were perfused with media alone) before being perfused with inhibitor (NNC – 10 
µM NNC 55-0396 for 6 minutes). Immediately following perfusion with the inhibitor (no rest 
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period), cells were exposed to a solution including both agonist and inhibitor (Ω+NNC, 20 
seconds). Cells were then exposed to a third application of Ω alone (Ω_3) and a final 
application of 3.2 µM progesterone (P4), both preceded by 4 minute rest periods.  
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Figure 3.15 – Typical single-cell Ca
2+
 imaging experiment testing inhibition of Ω-evoked Ca
2+
 responses by NNC 55-0396 
A. Typical [Ca
2+
]i recording: traces show normalized fluorescence plot for the whole cell population (blue dashed trace – 
Pop); cell 247 (orange trace), showing a Ca
2+
 transient when presented with 50 µM Ω in the presence of 10 µM NNC 55-
0396; and cell 561 (green trace), showing Ca
2+
 responses to all applications of the agonist on its own but not when this is 
presented together with the inhibitor. B and C. Inhibition of Ω-evoked Ca
2+
 signaling by 10 µM NNC 55-0396; data, plotted 
as percentage of cells responding ± SEM (B. and C. – left Y axis) or inhibition ± SEM (C. – right Y axis; see section 3.2.2 for 
inhibition definition), consists of 11 experiments, each including an average of 290 cells. Spermatozoa were labelled with 
7.5µM Ca
2+
 Green and 3.2μM progesterone (P4) was applied at the end of the experiment to verify cell’s physiological state 
and ability to generate Ca
2+
 signals. 
 
Traces in Figure 3.15 A. show averaged [Ca2+]i recordings for the whole cell population 
observed (dashed blue trace – Pop) and [Ca2+]i recordings for two individual cells, one which 
was able to develop a Ca2+ transient when co-applied odorant and inhibitor (Cell247 – 
orange trace), and another which, although responding to all applications of Ω alone, failed 
to develop a transient when co-applied odorant and inhibitor (Cell561 – green trace), 
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pointing to an inhibition of the Ω-evoked signal. This was true across samples (Figure 3.15 B. 
and C.), with 77.6±3.2% of the cells that responded to both Ω_2 and Ω_3 (27.9±6.8% of all 
the cells analysed) failing to respond when Ω was co-applied with NNC 55-0396. Oddly, 
exposure to the inhibitor on its own caused measurable Ca2+ transients in 72.9±3.8% of the 
cells (Figure 3.15 A. and B.). 
A detailed analysis of single-cell calcium experiments where spermatozoa were exposed to 
50 µM Ω in absence/presence of 10 µM NNC-550396, and limiting the analysis to cells that 
responded to all applications of the odorant alone (Ω1, Ω2 and Ω3 - ), revealed two distinct 
subpopulations: subpopulation A ( A), where cells failed to develop measurable calcium 
transients when odorant was co-applied with inhibitor (Ω + NNC 55-0396), and 
subpopulation B ( B), where cells developed a transient even in the presence of inhibitor ( A, 
red trace), although with much lower amplitudes than transients evoked by agonist alone in 
the same population. 
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Figure 3.16 – Kinetics of Ω-evoked Ca
2+
-transients 
Data represent fluorescence variations averaged from: A. 65 cells responding to applications of agonist alone (Ω1, Ω2 and 
Ω3 – green, brown and blue traces, respectively; Ω at 50 µM), but show no significant calcium transients when Ω was 
presented together with T-type calcium channel blocker NNC-550396 at 10 µM (Ω + NNC – red trace); B. 407 cells showing 
significant calcium transients for all agonist applications, both in absence (Ω1, Ω2 and Ω3) and presence (Ω + NNC) of T-type 
calcium channel blocker NNC-550396 (10 µM). In both A and B cells where exposed to a final application of 3.2 µM 
progesterone (P4 – grey trace) to verify physiological state and ability to generate Ca
2+
 signals. Inset boxplots show 
response distribution within cell populations observed (whiskers represent minimum and maximum fluorescence variation). 
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Table 2 summarises the differences in the response kinetics parameters from both 
populations. Response amplitudes were generally higher in subpopulation B, and this was 
particularly evident for the second and third applications of agonist alone (Ω2 and Ω3), 
together with progesterone, for which amplitude in population B is almost double the one 
observed for population A. On the other hand, transient durations for the first Ω application 
(Ω1) are higher in subpopulation B, whereas the delay between the application of the 
agonist and the onset of the transient is slightly lower than the one observed in 
subpopulation A. 
 
Table 2 – Kinetics parameters for Ω-evoked calcium signals in sperm cell subpopulations A and B in absence/presence of T-
type calcium channel inhibitor NNC 55-0396.  
Parameter 
Ω1 Ω2 
Ω+NNC 55-
0396 
Ω3 P4 
A B A B A B A B A B 
Amplitude (%) 10.4 11.5 22.5 30.9 - 5.4 22.2 37.8 25.5 46.4 
Duration (s) 55 75 62.5 57.5 - 75 50 50 170 170 
Delay (s) 20 15 12.5 12.5 - 15 15 15 7.5 10 
 
 
Additional to experiments above looking at potential effects by a range of inhibitors on Ω-
evoked Ca2+ transients, and because undecanal has previously been reported as a potent OR 
antagonist, suppressing signaling events elicited by bourgeonal and related compounds via 
OR1D2 (Spehr et al., 2003), a set of experiments was conducted to investigate if this 
chemical would also prove capable of antagonising Ω-evoked signaling (). There was a 
dramatic difference in the number of cells developing Ca2+ transients in response to both 
bourgeonal and Ω between capacitating and non-capacitating conditions: uncapacitated 
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cells responded to both agonists at a much lower rate than cells maintained under 
capacitating conditions ( A).  
 
 
Figure 3.17 – Antagonistic effect of undecanal on Ω and bourgeonal-evoked Ca
2+
 signaling in capacitated and uncapacitated 
spermatozoa 
A. Ca
2+
 signaling evoked by 50 µM bourgeonal and 50 µM Ω in presence/absence of equimolar undecanal, and B. 
corresponding inhibition (see section 3.2.2 for inhibition definition) of these signaling events by undecanal, both in 
capacitating and non-capacitating media. Motile spermatozoa were isolated by swim-up into sEBSS (capacitating media) or 
tyrode (non-capacitating media). Cells where exposed to a final application of 3.2 µM progesterone to verify physiological 
state and ability to generate Ca
2+
 signals. Data consists of 5 (capacitating conditions) and 3 (non-capacitating conditions) 
experiments, averaging 280 cells each. 
 
As expected from previous observations, 50 µM Ω elicited Ca2+ signals in 27.2±3.6% of the 
cell population, a value about 20 times higher than the one obtained under non-capacitating 
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conditions (1.4±0.7). Similarly, whereas under capacitating conditions 50 µM bourgeonal 
triggered calcium responses in 19.5±3.6% of cells, in non-capacitating media this value was a 
lot lower (1.5±0.6%).  
When co-presented with equimolar undecanal under capacitating conditions, 50 µM Ω 
caused Ca2+ transients in a larger number of cells (53.7±3.8%) than when presented on its 
own. The same happened under non-capacitating conditions, with 6.0±2.6% of cells 
developing Ca2+ transients to the Ω-undecanal mixture. Similarly, the level of responses to 
co-application of bourgeonal and undecanal was found to be higher than when bourgeonal 
was presented alone, both under capacitating (43.1±3.5%) and non-capacitating conditions 
(3.2±1.4%). The antagonistic effect of undecanal was assessed by looking only at the cells 
that responded to the initial application of either agonist and account for the ones that fail 
to develop measurable transients when the agonists were co-presented with undecanal ( B). 
Undecanal inhibition of Ω and bourgeonal-evoked signaling was found to be much higher 
under non-capacitating conditions than when cells were allowed to capacitate (54.2±29.2% 
versus 15.2±2.7% for Ω, and 79.2±15% versus 25.4±2.9% for bourgeonal).  
 
3.4. Discussion 
OR2AE1, an olfactory receptor with no identified agonists before the current work, is known 
to be ectopically expressed in mature human spermatozoa (Baker et al., 2007; Lefievre et al., 
2007). In chapter 2 a volatile organic compound, designated Ω, was identified as a potent 
agonist of the OR2AE1 receptor in a heterologous expression system via measurement of 
evoked calcium transients. As the starting information was native receptor protein 
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expression in sperm the current chapter has focused upon potential functional effects 
mediated by OR2AE1 in mature human sperm.  
Initial assessments were performed to confirm that Ω was able to trigger calcium signaling 
events in mature human spermatozoa. Capacitated sperm cells were exposed to 50 µM Ω, a 
concentration which proved effective in evoking calcium transients in the heterologous 
expression system (Figure 3.3), this induced calcium transients in a subpopulation of 
spermatozoa, with fluorescence variations of around 30%. These transients lasted around 60 
seconds () and proved to be re-evocable within minutes of previous stimulation. 
As 50 µM Ω was effective in induction of calcium signaling an experimental series was 
undertaken testing Ω concentrations between 50 nM and 500 µM to define the effective 
concentration range. The dose-response curve obtained resulted in a typical sigmoid curve 
with an EC50 of 6.2X10
-6 M (nonlinear curve fitting, Figure 3.4), indicating a response 
saturation between 50 and 500 µM, with the maximum percentage of cells responding to 
the agonist (33.6±4.3%) being observed at 500 µM. This was not an exhaustive dose-
response study for the drug-receptor pair and therefore should not be interpreted as such. 
The curve was drawn from data obtained across 4 experiments from a single sperm sample; 
detailed data with at least three samples within each molar denomination, as opposed to 
one, would be required to generate an accurate graph. The purpose of this subset of 
experiments was to determine a suitable concentration of agonist to be used in further 
investigations. Based on these results, 50 µM Ω was used in further experimentation as a 
reference concentration. 
Further testing of 50 µM Ω across a larger donor population (27 experiments across 6 sperm 
donors) revealed a substantial degree of variability in the percentage of spermatozoa within 
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each sample capable of developing measurable calcium signaling events in response to 
agonist application, both within and across sperm donors (Figure 3.5). Boxplots were used to 
illustrate the distribution of the percentage of cells responding to the third application of 
50µM Ω as these display differences between samples without the need to assume any 
particular statistical distribution (non-parametric), with the relative positioning of the bars 
and sizes of the box providing a good indication of the spread and skew in the data. The 
percentage of cells responding to Ω across sperm donors ranged from 9.4% to 46.6%, with a 
median value of 21.2%, representing a much more variable response pattern than what was 
observed for progesterone, which triggered responses in 79.0% of the cells, with a much 
narrower variation, as illustrated by and SEM value of 2.7%. Thus, Ω shows a broad range of 
responsiveness, which could be explained by heterogeneity of the sperm samples in terms of 
numbers of cells expressing the receptor, allied to the complexity of potential signaling 
events occurring within the sperm cell (Publicover et al., 2007). As discussed below, the 
signaling events evoked by Ω appear themselves to comprise a certain degree of variability 
and complexity, proving to be dependent on capacitation state of the cell population and 
also appearing to be sensitive to a priming effect by the initial exposure to the agonist with it 
triggering more cells to respond to subsequent Ω applications. 
Data gathered from experiments where cells were sequentially exposed to four applications 
of 50 µM Ω indicated a complex response pattern within the cell population, with some cells 
proving able to develop transients from the first exposure to the agonist whereas others 
would only respond to the agonist after one or more previous exposures (Figure 3.6). The 
percentage of cells responding to Ω rose from the first application (11.7±1.8%) to the fourth 
(29.1±4.5%), but this rise was only found to be statistically significant from application one 
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to application two, possibly indicating that the first exposure to Ω has a priming effect on a 
fraction of the cell population, increasing these cell’s responsiveness to the odorant. This 
was not observed in the heterologous expression system, where the number of cells 
responding to the first application of Ω was generally higher than cells responding to the 
second agonist application (Figure 2.7 and Figure 2.8). This difference in re-evocability 
between spermatozoa and HEK 293 cells could partially be explained by the low rate of 
functional expression of OR2AE1 in the heterologous system, in which odorant receptors 
tend to be internalised after odorant stimulation (Mashukova et al., 2006).  
As mentioned above, the ability of Ω to trigger calcium signaling events in human sperm was 
also found to be strongly dependent on the capacitation state of the sperm population 
(Figure 3.7). The experimental conditions were designed to favour capacitation, by 
maintaining cells in medium including adequate levels of calcium, bicarbonate and albumin 
(Cross, 1998; Gadella and Harrison, 2002; Harrison, 2004; Visconti et al., 1999). The 
association between the percentage of cells responding to the third application of agonist 
and the time they were allowed to capacitate resulted in a high positive correlation between 
both variables illustrated by the two-tailed Pearson’s correlation coefficient (r=0.57, 
p<0.0003). This high linear dependence between variables was only found to be true for 
capacitation times between 3 and 12 hours, with the linear model failing to fit the 
association between variables for incubation times above 12 hours. These data 
unequivocally show that the subpopulation of spermatozoa capable of developing Ca2+ 
signaling when exposed to Ω increases for higher capacitation times, suggesting that the 
signaling mechanism could be kept more or less dormant before capacitation occurs, 
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coherent with a possible integration of these signaling events with a potential guidance 
mechanism.  
The idea that ORs could be playing a significant role in a possible in vivo sperm guidance 
mechanism in human has been gaining increasing support since the landmark publication by 
Spehr et al., 2003, showing that in vitro, human sperm are chemotacticaly attracted to 
bourgeonal, an odorous molecule responsible for the smell of the lily-of-the-valley. Similarly, 
the current work has also given rise to the question of whether Ω would trigger identical 
behavioural effects in human sperm. To this effect, a new experimental method was 
designed to investigate potential chemotactic effects of odorants in human spermatozoa. As 
described in section 3.2.3, motile spermatozoa were maintained under capacitating 
conditions and exposed to odorant gradients formed by 5, 50 and 500 µM solutions of both 
Ω and bourgeonal. A simple set-up was used whereby micropipette tips filled with odorant 
(or control) solution were dipped in a suspension of motile spermatozoa (Figure 3.1) and 
then incubated for 1 hour to allow for gradient formation, and potential cell response to the 
gradient. The molecules tested are relatively similar in terms of overall molecular charge and 
size, and therefore a constant diffusion coefficient of 5.7x10-6 cm2/s, calculated according to 
Hayduk-Laudie method (appropriate for modelling diffusion of low concentrations of low 
charge molecules in aqueous solutions – Hayduk and Laudie, 1974), was assumed for the 
modelling of gradients established by the different solutions of Ω and bourgeonal (see 
section 3.2.3 for modelling method). Figure 3.2 shows a graphical representation of the 
theoretically modelled gradient formation for the three odorant concentrations used: 5, 50 
and 500 µM odorant concentrations form a stable gradient after just a few minutes, allowing 
sperm cells to be exposed to the chemical, “read” the gradient, and potentially change 
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direction in response to it. As expected, bourgeonal, reported as a potent chemoattractant 
towards human sperm (Spehr et al., 2003), has caused more cells to travel up the pipette tip 
than control (Figure 3.8), and this effect proved dose-dependent, ranging from 50.9±23.2% 
(for 5 µM bourgeonal) to 94.9±64.9% (for 500 µM bourgeonal). Excitingly, in these 
conditions, 50 µM Ω was significantly more potent (approximately 2X) than the best 
performing concentration of bourgeonal, causing 204.6±7% more cells to accumulate in the 
pipette tip than the control solution. However, unlike what was observed for bourgeonal, 
the accumulation effect caused by Ω was not dose-dependent, dropping sharply for 500 µM 
Ω (23.5±29.1%). This drop could possibly relate to the increased AR rates observed when 
sperm were exposed to the same Ω concentration (Figure 3.9). At this level the odorant 
causes a significant increase in AR stimulation (24.6±15.8%), much higher than what was 
observed for 5 and 50 µM (1.2±2.1% and 0.1±2.8%, respectively). The fact that 500µM but 
not lower concentrations of Ω trigger AR shows that at this level, the odorant has a distinct 
physiological effect, possibly evoked via a different mechanism, which translates into lower 
concentrations tested causing a much higher accumulation effect than 500µM Ω. Although 
the method used did not allow the distinction of whether the accumulation effect observed 
was due to a chemotactic or a chemokinetic phenomenon, it nevertheless allowed a robust 
and expedite method to test the effect of different odorants on sperm accumulation on the 
pipette tip by screening a large number of samples, which would be a lot more time-
consuming with alternative methods. On the other hand, and as further discussed below, a 
more detailed investigation on the effect of 50 µM Ω on sperm motility carried out both by 
CASA (Supp. Figure 4 and Supp. Table 1 - Appendix II: Supplementary Data) and modified 
Kremer test () failed to identify significant differences in motility exhibited by spermatozoa 
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exposed to the odorant and their parallel controls for all the parameters analysed. If 50 µM 
Ω would indeed trigger a significant chemokinetic effect in capacitated human sperm, CASA 
would arguably be the best method to identify it, but as this was not the case, the possibility 
of the accumulation effect discussed above being due to chemokinesis and not chemotaxis is 
fairly remote.  
The chemotactic assay design differs in complexity from those carried out by other workers 
(Eisenbach and Tur-Kaspa, 1999; Spehr et al., 2003; Teves et al., 2009) with one particular 
difference being that direct observation of the sperm moving towards or away from the 
source was not possible. However, an advantage of an ‘accumulation at maximum 
concentration’ assay was the substantial number of sperm that could be counted (> 500 cells 
per replicate) to provide a robust result for statistical analysis. It is possible to argue within 
this system that the sperm inside the pipette tip may have become ‘trapped’ there due to 
hyperactivated motility at the maximum concentration, however, as discussed later, 
although 50 µM Ω did induce changes in the number of hyperactivated cells, these proved 
non-significant, and the very low actual numbers of these (generally under 8%) within the 
cell population observed would be unlikely to account for the large variations observed in 
the chemotaxis assay. In any case, within the non-physiological situation of low viscosity 
media (Kirkman-Brown and Smith, 2011) this observation is as accurate as any other. 
The method used to test for chemotaxis did not, however, intend to model or correlate to a 
possible chemotactically-driven guidance mechanism in the human FRT. As discussed by 
Gadelha et al., 2010, the viscosity sperm are exposed to will affect cell trajectory and 
movement, so for a chemotaxis assay to mimic in vivo environment, and as reviewed by 
Kirkman-Brown and Smith, 2011, such method should approximate the media viscosity to 
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the levels sperm experience in the FRT. Here they navigate their way to the ovum by 
traversing mucus coating the tract surfaces and they experience viscosities much higher than 
the ones in standard media used in in vitro studies. However the increased times to set up a 
gradient by diffusion in such a system (described in Kirkman-Brown and Smith, 2011) 
precluded these experiments. In future, development of photo-labile versions of the Ω 
molecule as derived for progesterone by Ben Kaupp’s group (Kilic et al., 2009), may make 
these experiments feasible.  
Early observations by Cohen-Dayag et al., 1994 show than only 2-12% of the sperm 
population is chemotactically responsive to active factors in follicular fluid at any given time, 
and, as later reviewed by Eisenbach and Tur-Kaspa, 1999, it is likely that only the capacitated 
fraction of the sperm population is capable of chemotaxis, so the effect this may have needs 
to be considered when interpreting results obtained with the chemotaxis assay described in 
the current work. As discussed for Figure 3.7, capacitation time itself has an effect on Ω 
induction of calcium signaling, but at this stage it is unclear whether there is in fact a further-
rarefied chemotactically-active sub-population within motile spermatozoa, and whether 
those cells are all in the same capacitation stage. In order to even begin to answer this 
question, detailed observation of sperm motility in gradients alongside calcium imaging, 
probably by photo-labile compounds as discussed above, would be required.  
A secondary question to the drop-off in chemotaxis observed at 500 µM Ω was whether 
other non-motility signaling pathways may have been activated, hence acrosome reaction 
rates were examined. It was clearly shown that 5 and 50 µM Ω had no effect on acrosome 
reaction, however 500 µM Ω did cause a significant rate of induction (Figure 3.9). 
Interestingly, no difference was observed in response kinetics for 50 and 500 µM Ω (Supp. 
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Figure 5) which, together with the effect in acrosome reaction, could indicate that at 500 µM 
Ω begins to stimulate other pathways beyond those involved in motility modulation, without 
noticeable effects in [Ca2+]i. For three other recently characterised receptor systems 
(Veitinger et al., 2011) the agonists were only assayed up to 10-5 levels for acrosome reaction 
effects and no differences in spontaneous AR rates were observed, so this data is in 
agreement over that range. Veitinger et al., 2011, did report that at these lower levels the 
sperm obtained within the microcapillary system they employ were more responsive to a 
non-physiological inducer of acrosome reaction (phorbol 12-myristate 13-acetate). Future 
examination of the responsiveness of the sperm population collected in our 
chemotaxis/accumulation assay both in calcium imaging and acrosome reaction experiments 
would be very interesting, though use of the physiological agonist progesterone may give a 
more meaningful result. It is not clear whether investigation of the 500 µM Ω AR-inducing 
effect is worthwhile: if a potential physiological agonist of OR2AE1 is secreted or synthesised 
within the cumulus egg complex, it is entirely possible that at the last stage of their journey 
sperm may encounter the agonist at this concentration range. This differing signal/action at 
different stages of sperm migration would be a very effective and efficient use of the 
sperm’s signaling toolkit by possibly integrating this and other agonist signals, such as those 
of the ZP, in the ultimate accomplishment of the gamete’s objective - fertilisation. However, 
until a physiological agonist is defined this remains pure speculation. 
As the exact location of any physiological OR2AE1 agonist within the female tract is 
unknown, the effects of semen exposure to 50 µM Ω - the equivalent of sperm seeing the 
agonist in the vaginal environment - and subsequent migration effects were examined (). In 
this situation no significant effects on the percentage of sperm migrating up the capillary 
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were observed. It is worth noting that there were slightly fewer (NS) sperm observed at 4 cm 
versus control: this could be consistent with a potential small number of chemotactically-
active cells being attracted back towards the semen which contained the chemoattractant Ω.  
Additionally, potential effects of 50 µM Ω in sperm motility were investigated by computer 
assisted semen analysis (CASA). The results showed no significant differences between 
stimulated and control spermatozoa (Supp. Figure 4 and Supp. Table 1 - Appendix II: 
Supplementary Data) although a clear trend is present when looking at hyperactivation 
markers (sorts 5 and 7 - Figure 3.11). Samples stimulated with the odorant tend to exhibit 
higher number of cells classed as sort 5 and 7 (see section 3.2.6 for sort definition), and this 
is particularly evident 30 minutes after stimulation: when compared to control, 72±38% and 
117±82.2 more cells were sort 5 and sort 7, respectively. Although these differences did not 
prove statistically significant (results for sort 7 and sort 5 at T30 are borderline – ANOVA, p = 
0.053 and 0.078 respectively) they hint to the possibility of Ω having a hyperactivation effect 
on a subpopulation of human sperm. The results could have failed to show this effect in a 
more robust manner possibly due to the high variability observed, both across and within 
sperm donors. The data set could therefore benefit from being amplified across a larger 
number of donors, so that the referred variability would have a smaller weight on the 
observation.  
It would also be interesting to know if cells remain hyperactive for as long as the odorant is 
present or if they go in and out of hyperactivation, with different cell subsets being 
hyperactive at any given time, and maybe by different odorant concentration ranges. If the 
latter is observed to be true, it could be that a potential OR2AE1 agonist within the FRT 
would have multiple effects in modulating sperm motility, be it, as discussed earlier, through 
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a more direct chemotactic guidance mechanism, or, through a less directional effect, causing 
cells to randomly change direction when going in and out of different hyperactive states, 
therefore maximizing the chance of “selected” sperm to find the oocyte and possibly 
providing them with the right motility to penetrate cumulus when they do. In any case, 
further and more detailed observations of the effects of Ω on sperm motility and 
hyperactivation under the right physiological conditions (the right viscosity being 
paramount, as mentioned earlier), would be essential to clarify this question.  
In a preliminary attempt to localise the subcellular onset of calcium signals observed when 
sperm were stimulated with 50 µM Ω, a set of experiments was carried out where 
immobilised spermatozoa were exposed to the agonist for a short period (20 seconds) and 
[Ca2+]i was monitored at 12.5 Hz for 70 seconds, from the beginning of the application, by 
florescence microscopy (Figure 3.12). For this set of experiments, a good compromise 
between excessive light exposure (if a ratiometric dye was to be used) and adequate 
temporal resolution allowing for distinction of signal propagation was achieved by the use of 
a single-wavelength Ca2+ indicator (Calcium Green-1 AM). Also, given the preliminary 
character of these investigations and the difficulty to obtain reliable data for other areas of a 
fast moving flagellum, only sperm head and midpiece were included in the analysis as main 
general areas of the sperm cell.  
For the majority of the cells observed, the signal tended to initiate in the midpiece, with a 
mean delay of 1.36±0.51 seconds before it would propagate to the head. The delay observed 
proved statistically different (one-sample t test; t(30)=2.678, p<0.012) from a hypothetical 
zero delay (simultaneous signal onset in head and midpiece), indicating OR2AE1 receptor, 
together with immediate elements involved in the signal transduction, will probably localise 
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to the midpiece rather than the head. Although from a less detailed analysis, these results 
are consistent with what was previously reported by Spehr et al., 2004 (localisation and 
signal transduction via OR1D2) and more recently by Veitinger et al., 2011 (signal 
transduction via OR7A5 and OR4D1) for other ORs found in human sperm, showing that 
calcium transients evoked by OR agonists tend to initiate in either the midpiece or proximal 
flagellum and propagate to the sperm head within < 4 seconds.  
Further characterisation of the signaling evoked by Ω in human sperm involved the use of a 
series of inhibitors of key molecules crucial for the transduction of calcium signals (). Spehr 
et al., 2004 have shown that, similar to OR signaling in sensory neurons, the calcium signals 
evoked in human sperm by OR1D2’s agonist bourgeonal involve an increase in cAMP 
catalysed by the membrane-associated adenylyl cyclase (mAC), but other authors 
acknowledge a significant role for the IP3 pathway in vertebrate olfactory signal transduction 
(Ko and Park, 2006). More recently two independent groups (Strunker et al., 2011 and Lishko 
et al., 2011) have identified the sperm-specific Ca2+ channel CatSper as the main molecule 
mediating the Ca2+ influx triggered by progesterone in human sperm. This subset of 
experiments, therefore, aimed at using the pharmacological tools available to gain some 
insight on what molecules are involved in the transduction of the Ca2+ signal observed when 
human sperm were exposed to Ω. To this end, inhibitors acting on the cAMP pathway (SQ 
22536 and cAMPS-Rp), IP3 pathway (U 73122) or blocking Ca
2+ influx via CatSper (NNC 55-
0396 - T-type calcium channel blocker) were tested for their ability to block the Ω-evoked 
Ca2+ signals (). Both SQ 22536 (a specific P-site known to block all 9 isoforms of mAC - Hurley, 
1999) and cAMPS-Rp (cAMP analogue that acts as a competitive antagonist of the cAMP-
induced activation of PKA - Van Haastert et al., 1984) caused a substantial reduction in the 
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number of cells responding to Ω, with inhibitions of 66.3±11.1% and 72.0±14.9% 
respectively. SQ 22536, a P-site inhibitor, is known to block all isoforms of mAC without 
interfering with sAC activity (Sunahara and Taussig, 2002 and Hurley, 1999). Interestingly, 
the inhibitory effect of SQ 22536, over Ω signals was achieved with a much lower dose (10 
µM) than the one required to block bourgeonal-evoked signals in human sperm (10 mM), as 
reported by Spehr et al., 2004. This could indicate a more specific action of the inhibitor, 
meaning the Ω-evoked Ca2+ signal is therefore more dependent on mAC activity than the 
similar response reported for bourgeonal. 
Interfering with the IP3 pathway by blocking PLC (U73122 - Bleasdale et al., 1990), on the 
other hand, resulted in a much lower inhibition of the agonist-evoked response (11.7%), 
whereas blocking T-type Ca2+ channels yielded the highest level of inhibition (77.6±3.2%).  
At this stage, however, it is essential to consider the effects of the biochemical tools used in 
these experiments. A particular problem when employing any inhibitor are the immediate 
effects that they may induce. These could be specific via their action, or non-specific and 
unrelated. Immediate inhibitor-related responses in baseline calcium were observed across 
the four inhibitors employed and some were found to be substantial (Figure 3.14).  
SQ 22536 had the least effect on baseline calcium; presuming the effect was specific, this 
would indicate that a resting cell had little mAC activity that was related to resting [Ca2+]i 
homeostasis. This contrasts to the more dramatic effects of cAMPS-Rp, which if specific, may 
indicate that there is PKA activity in ‘resting’ sperm, the implication being that PKA inhibition 
causes a steady increase in cAMP, which apparently, is not being recycled at a fast enough 
rate by the phosphodiesterases (PDEs). As discussed below, the mechanism by which this 
rise in cAMP originates the elevation in [Ca2+]i observed is unknown, but it seems likely that 
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CatSpers are being activated either directly or indirectly by the elevated cAMP resulting from 
blocking PKA. However, further experiments combining the use of cAMPS-Rp with SQ 22536 
and NNC 55-0396 would be required to reveal whether these hypotheses are likely, or 
effects are more non-specific and artefactual.  
Interference with the IP3 pathway by inhibiting PLC has also resulted on an elevation in 
[Ca2+]i: if specific, the effect of U73122 on baseline calcium would be via switching-off of 
resting PLC activity, the later sustained effects on [Ca2+]i could then likely relate to accrual of 
earlier phosphoinositides in the pathway, which may have a myriad of other signaling effects 
as discussed by Michell, 2009. Furthermore, effects other than the inhibition of PLC have 
previously been described for U73122 in other cellular systems: Mogami et al., 1997 have 
described U73122 as capable of directly activating ion channels and triggering Ca2+ release 
from intracellular stores in mouse pancreatic acinar cells.  
The observed responses to NNC 55-0396, also recently reported by Strunker et al., 2011, are 
more difficult to understand: at present these would appear to be a non-specific response, 
however, a role of the CatSpers in a baseline-level resting cell divalent cation leak – which 
when inhibited caused sperm to generate a further large response through a different 
system, cannot at this time be ruled out. The inhibition of the Ω response by NNC 55-0396 
was the subject of a more detailed analysis, looking not only at variations in the cell 
populations observed (Figure 3.15), but also at the kinetics of the Ca2+ transients evoked by 
Ω in presence or absence of the inhibitor (). The majority of cells (72.9±3.8%) developed 
transients when presented with 10 µM NNC 55-0396 (Figure 3.15 A and B). However, the 
response pattern displayed by the cell population when looking at inhibition (see section 
3.2.2 for definition) of Ω-evoked Ca2+ transients (Figure 3.15 C) is somewhat harder to 
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interpret. Only 27.9±6.8% of cells respond to applications 2 and 3 of the agonist (cell 
population used for inhibition calculation purposes); of these, 20.9±5.0% do not develop 
transients when agonist is co-presented with inhibitor (population A -  A), resulting in 
77.6±3.2% inhibition, but 7.0±2.3% of cells will still show measurable transients (population 
B -  B). The differences in kinetics for these two spermatozoa subpopulations (, summarised 
in Table 2) show that population B is overall more responsive that population A, with higher 
amplitude transients. This is particularly evident for the second and third applications of 
agonist alone (Ω2 and Ω3), but also progesterone, for which amplitude in population B is 
almost double the one observed for population A. Consistent with earlier results showing Ω 
stimulation as capacitation dependent, these differences could certainly relate to cells in 
different capacitation stages, with some cells further ahead in the capacitation process and 
therefore ready to respond to potential stimuli, and others taking longer to capacitate and 
only being responsive later in the process. If a chemotactically active agonist for OR2AE1 
indeed exists in the FRT, such populational heterogeneity would probably result in an 
increased fertility potential, since the period in which chemotactically-capable cells would be 
available for stimulation would consequently be extended, allowing for a better synchronism 
with the female fertility window.  
In any event, on the subject of the effects triggered by the inhibitors themselves, the data 
for the mAC – cAMP – PKA pathway obtained with SQ 22536 would seem the most robust 
and least likely to be totally at fault, as it results on a lower resting [Ca2+]i and still evidencing 
effective inhibition of the Ω response, but interpretation of Ca2+ signals triggered by all these 
compounds, but particularly NNC 55-0396, U73122 and cAMPS-Rp is complicated for their 
many implications. When interpreting agonist + inhibitor responses, these signals could 
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result in a number of unknowns: perhaps the higher levels of calcium would mean that a 
receptor or channel involved in Ca2+ intake, if voltage sensitive, would not be able to 
depolarise and therefore partially or completely stop working; another possibility would be 
that the raised Ca2+ would be affecting other components down the signaling cascade. One 
of such molecules could be sAC, whose activity is modulated by different cytosolic calcium 
levels, as reviewed in Kamenetsky et al., 2006.  
Taken together, results obtained for the different inhibitors show that the Ca2+ signal evoked 
by Ω is dependent on the conversion of ATP to cAMP by one or more membrane associated 
isoforms of adenylyl cyclase. The involvement of the IP3 pathway in this response appears 
minimal, but importantly, CatSper proved a major player, mediating a significant Ca2+ influx 
after stimulation with Ω, observed as a large increase in [Ca2+]i.  
 
 
 
Figure 3.18 – Proposed transduction mechanism for the Ω-evoked signals in human spermatozoa 
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The information available at the moment is insufficient to provide an absolute model of how 
the Ω-evoked signal is transduced (Figure 3.18). Nonetheless, it seems likely that, similar to 
chemosensory transduction on OSNs, stimulation of the OR2AE1 in human sperm causes 
activation of mAC, via the alpha subunit of the receptor complex Golf, previously shown to 
co-localise with isoform III of the membrane-bound adenylyl cyclase (mAC III) in human 
sperm’s flagellum and midpiece (Spehr et al., 2004). As observed by others (Aoki et al., 1999; 
Ren et al., 2001; Wiesner et al., 1998), the rise in cAMP levels leads to increased [Ca2+]i. It 
seems likely that the elevation in [Ca2+]i results mostly from CatSper stimulation (or arguably 
other T-type Ca2+ channels), since the Ω response is also largely blocked by NNC 55-0396, but 
Ca2+ influx via CNG may also play a role in [Ca2+]i observed after stimulation, as a CNG is 
known to be present in mammalian sperm (Parmentier et al., 1992). However, the way the 
cAMP rise results in CatSper stimulation is still elusive and a current subject of discussion 
(see review by Ren and Xia, 2010). The possibilities of Ω acting directly on CatSper, or 
indirectly stimulating the channel by association of the OR complex or some of its 
components with CatSper, similar to what is seen insect OSNs, where a receptor/channel 
complex exists (Kaupp, 2010; Sato et al., 2008; Wicher et al., 2008), cannot be excluded, but 
the results obtained by interfering with the cAMP pathway suggest that most of the 
stimulation is channelled through mAC. Furthermore, the differences when comparing 
kinetics of Ω and progesterone-evoked Ca2+ signals ( and Table 2) strongly suggest an indirect 
activation of CatSper by the rise in second messenger cAMP caused by Ω stimulation, with 
the Ω-evoked transients taking longer to develop than the ones evoked by progesterone, 
which according to recent evidence (Lishko et al., 2011 and Strunker et al., 2011), causes 
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Ca2+ influx by directly activating CatSper. In any case, independent of which mechanism 
causes CatSper activation after Ω stimulation, the resulting rise in [Ca2+]i is likely to be crucial 
in the regulation of capacitation and likely hyperactivation, as evidenced by the increased 
number of hyperactivated cells observed in sperm samples exposed to the agonist (Figure 
3.11). 
To examine the possibility of Ω stimulating other sperm ORs other than OR2AE1, we took 
advantage of the only agonist/antagonist pair characterised so far for human ORs (OR1D2, 
whose activation by bourgeonal is reported to be inhibited by undecanal - Spehr et al., 
2003), a set of experiments were conducted to investigate the effect of undecanal on the Ω-
evoked response (). Our standard capacitating media system was employed alongside a non-
capacitating media which did not contain bicarbonate or serum, as this mirrors that 
employed by Spehr et al., 2003 for their work. Effects of both bourgeonal and Ω on [Ca2+]i 
proved fundamentally different depending on the capacitation state of the sperm 
population, with spermatozoa maintained under capacitating conditions responding in much 
greater numbers to both agonists than cells kept in non-capacitating media. Similarly to 
what was seen for the Ω-evoked response, sequential exposure to bourgeonal resulted in an 
overall increase in the number of cells responding to the odorant. The responsive population 
proved dynamic, with the population responding at any given application not including all 
which had previously responded. 
The presence of Undecanal with bourgeonal or Ω, in capacitating or non-capacitating 
conditions, revealed an increase in the number of cells responding. It was unclear whether 
this increase in the responsive population was due to undecanal or simply a further exposure 
of cells to the other agonist. To investigate the classification of individual cells previously 
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responding to bourgeonal was investigated to see how many subsequently responded. 
Surprisingly, even in this situation the inclusion of bourgeonal on the experimental set-up as 
a positive control for undecanal inhibition revealed a relatively low level of inhibition 
(25.4±2.9%) compared to the total inhibition of Ca2+ responses reported for sperm 
presented with equimolar doses of bourgeonal and undecanal reported by Spehr et al., 
2003.  
The results reported by Spehr et al., 2003 apparently refer to observation of spermatozoa 
kept under non-capacitating conditions, but interestingly, the antagonistic effect of 
undecanal observed on our system over both bourgeonal and Ω was much higher on non-
capacitated cells (79.2±15% and 54.2±29.2%, respectively) than when cells were kept in 
capacitating media (25.4±2.9% and 15.2±2.7%, respectively). This would suggest that the 
molecular mechanism responsible for the relatively high antagonistic properties of 
undecanal under non-capacitating conditions is to a big extent abolished under capacitating 
conditions. Whether this results from a metabolic change inherent to the complex 
capacitation process or if the different media used cause the odorants to interact differently 
with the receptors is speculative. However, a possible factor allowing for the striking 
differences in number of cells responding to the agonists in capacitating and non-
capacitating media could be the major reconfiguration of the sperm’s plasma membrane 
during the capacitation process itself, recognised to radically alter the cell’s function. 
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4. FUNCTIONAL INVESTIGATION OF BORONIC ACIDS IN 
HUMAN SPERMATOZOA 
4.1. Introduction 
One in six couples in the developed world experience subfertility (Hull et al., 1985) and male 
factor infertility explains over half of all cases, with the motility of the sperm being the major 
problem – not the more often publicised sperm count.  
Sperm motility is crucial to natural conception and its improvement or modulation is 
arguably the safest and least invasive way to improve fecundity levels. A key but less well-
known action of the female hormonal contraception pill is to thicken the cervical mucus and 
hence prevent sperm migration (Benagiano et al., 2009), hence there is significant potential 
for interventions which may affect sperm’s ability to migrate. 
Migration of sperm inside the human female reproductive tract is fraught with many 
challenges including, but not limited to, dramatic changes in viscosity (Wolf et al., 1977); 
osmolarity (Yeung et al., 2003); many surrounding chemical modulators, including 
progesterone (reviewed in Correia et al., 2007); and glycodelin proteins (Seppala et al., 
2007); nitric oxide (Machado-Oliveira et al., 2008); and potential phagocytotic attack from 
leucocytes (Pandya and Cohen, 1985). These challenges mean that in just a few hours the 
many millions of sperm deposited in the vagina are reduced to hundreds in the fallopian 
tubes (Williams et al., 1993) or even as few as ten reaching the oocyte (Nottola et al., 2001). 
Many of these factors and their interplay are excellently reviewed in Suarez and Pacey, 2006. 
In section 3 the rapidly evolving world of odorant receptor research is discussed and data for 
characterisation of the effects of one of these (OR2AE1) and associated chemotaxis thought 
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to occur higher within the female tract is discussed. However, all of these studies have failed 
to take into account the fundamental biological differences in viscosity and how that may 
affect the observations (Kirkman-Brown and Smith, 2011). A different question is whether 
sperm in semen can be ‘improved’, or ‘more’ sperm can be made to migrate from semen 
and colonise the cervical mucus by affecting their motility. As to date, there is no specific 
drug treatment available to improve the function of the sperm cell. Treatments for male 
problems are mainly restricted to IVF, implying consequent risky procedures for the female, 
and therefore there is a potential to develop drug regimes to stimulate sperm function.  
Previous methods aimed at assisting sperm function have been limited to the use of cellular 
signaling pathway inhibitors (IVF), or adding a natural ligand, Platelet Activating Factor (PAF) 
(Roudebush et al., 2004) to prepared sperm for artificial insemination (IUI). Both of these 
methods have significant drawbacks as they are invasive, costly and cause patient 
embarrassment.  
Ongoing research into human sperm motility regulation in our laboratory identified a novel 
boronic acid compound which showed promise in significantly increasing the number of 
sperm that migrate through a cervical mucus analogue – this is a test which mimics what 
sperm have to undergo in-vivo and hence a strong predictor that more sperm in an ejaculate 
mixed with this compound would manage to get through the female reproductive tract.  
This section of the current work sets out to validate whether sperm enhancing capabilities of 
the compound and characterise the method of boronic compound action in human 
spermatozoa, hypothesising that it may either be through olfactory g-protein coupled 
receptors or via a direct effect of binding saccharide moieties on the cell-surface. 
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4.2. Material and Methods 
4.2.1. Sperm preparation / capacitation 
Sperm were prepared and capacitated according to previously described methods, see 
section 3.2.1. 
 
4.2.2. Single cell calcium imaging 
The core set of single-cell imaging experiments were performed according to previously 
described methods (see Section 3.2.2), with the adjustment that instead of odorants, 
phenethylboronic acid (PEBA) at a final concentration of 10 nM was perfused as the agonist. 
Initial 5M stocks of PEBA (Sigma UK Ltd) were made up in 1:1 DMSO:npH2O. These were 
serial diluted in H2O to intermediate stocks, which were then freshly diluted (1:100 in sEBSS) 
to their final working concentration on the day when experiments took place. High speed 
imaging and experiments with inhibitors were as described in section 3.2.2, but employing 
10 nM PEBA as the agonist. 
 
4.2.3. Migration assay 
The ability of boronic acids to affect sperm migration were assessed according to previously 
described methods, see Section 3.2.5, by modified Kremer assay. Migration tests were 
performed in duplicate: two capsules (BEEM capsule, G360-2, Agar Scientific, Stansted, UK) 
were filled with 50 µl of semen pre-mixed with either test (2 different boronic acids at 40 nM 
in PBS pH 7.4 with 1:50,000,000 DMSO) or control (PBS pH 7.4 with 1:50,000,000 DMSO) 
solutions on a 3:1 ratio. One capillary was placed vertically into each capsule so that the 
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hyaluronic acid was in direct contact with the semen. Assembled setups were then 
incubated (37°C, 5% CO2) for 1 h, after which cell number along the capillary (10, 20, 30 and 
40 mm from the lower end) was assessed. Assessment was done at 200X total magnification 
using phase-contrast microscopy on an upright Olympus BX50 microscope. 
For experiments testing sperm motility / migration enhancers in conjunction with key 
pathway inhibitors, an extra boronic acid (boric acid -BA) and caffeine were included (final 
concentrations of 10 nM and 1mM, respectively) in the assay described above, and tested 
together with 5 µM U 73122 and 25 µM cAMPS-Rp.  
 
4.2.4. Acrosome reaction 
Acrosome reaction induction was performed and assessed according to previously described 
methods (see 3.2.4), but in this case employing a range of PEBA concentrations, diluted 
(1:100) from appropriate stock solutions (see section 4.2.2). 
 
4.3. Results 
4.3.1. PEBA evokes Ca2+ signaling events in human spermatozoa 
Using a different approach to that described in chapters 2 and 3, previous research on our 
lab has identified phenethylboronic acid (PEBA) as a potential enhancer of sperm migration 
in vitro. The effects of this compound on Ca2+ signaling were assessed by single-cell calcium 
imaging, as described in section 4.2.2. A range of PEBA concentrations was tested for their 
ability to cause Ca2+ transients in capacitated human spermatozoa. Figure 4.1 represents a 
typical experiment where sperm were exposed to subsequent applications of increasing 
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concentrations of PEBA (3 pM to 100 nM). The green trace shows an individual cell (cell2) 
developing Ca2+ transients when exposed to PEBA in the pM (30 pM) and nM (1, 10 and 100 
nM) ranges, whereas cell26 (orange trace) only responds to 100 nM PEBA.  
 
Figure 4.1 - Ca
2+
 responses to increasing concentrations of PEBA 
Typical [Ca
2+
]i recording: traces show normalized fluorescence plot for the whole cell population (blue dashed trace – Pop) 
and 2 individual sperm cells (cell 2 – green trace; cell 26 – orange trace). Spermatozoa were labelled with 7.5µM Ca
2+
 Green 
and sequentially perfused for 20 seconds with increasing concentrations of PEBA (3 pM, 30 pM, 300 pM, 1 nM, 10 nM and 
100 nM). 3.2μM progesterone (P4) was applied at the end of the experiment to verify physiological state and ability to 
generate Ca
2+
 signals. 
 
 
There was variability in the number of cell responding to each PEBA concentration, and this 
is reflected on the average fluorescence variation of the whole cell population observed (Pop 
- dashed blue trace), indicating that the number of cells responding to PEBA increases for 
higher concentrations of the chemical.  
Following on initial assessment on whether PEBA was capable of triggering Ca2+ signaling 
events in human sperm, a broader range of concentrations was tested to define the optimal 
concentration to be used in subsequent experiments. The dose-response curve (Figure 4.2) 
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drawn for PEBA concentrations ranging from 3 fM to 100 µM shows an obvious trend where 
higher levels of the chemical cause more cells to develop Ca2+ transients. However, unlike 
typical dose-response curves, the non-linear fit of the curve proved unsuitable to describe 
the trend observed (dashed green line). In this case, a linear regression analysis provided a 
better fit for the values observed, reporting a moderate correlation between percentage of 
cells responding and the logarithm of PEBA concentration (R2 = 0.31). The fact that PEBA 
concentrations in the nM range are sufficient to cause 80% of cells to respond can be 
indicative of a high potency agonist acting on a system characterised by the receptor-reserve 
phenomenon, where the maximum response is achieved with only partial occupancy of the 
receptor pool. 
 
 
Figure 4.2 – Dose-response for Ca
2+
 responses evoked in mature sperm by PEBA 
Sperm cells were allowed to capacitate for at least 5 hours, labelled with 7.5µM Ca
2+
 Green and exposed to 20s applications 
of increasing PEBA concentrations (from 3 fM to 100 µM). Data, plotted as percentage of responding cells ± SEM, consists of 
8 experiments, each including an average of 280 cells.  
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4.3.2. Effect of PEBA on sperm migration 
In order to further validate previous results indicating PEBA was capable of enhancing in 
vitro sperm migration, human spermatozoa were exposed to 10 nM PEBA in a modified 
Kremer test (section 4.2.3), alongside the same concentration of another boronic acid 
(HMPBA - 2-(Hydroxymethyl)phenylboronic acid cyclic monoester) that also proved effective 
in in previous testing in our laboratory (Figure 4.3). At this concentration, PEBA caused a 
significant increase in sperm numbers at all distances scored along the capillary, ranging 
from 43.1±14.3% (1 cm) to 77.0±16.2% (2 cm) when compared to control.  
 
 
Figure 4.3 – Effect of PEBA and HMPBA on sperm migration 
Both PEBA (green) and HMPBA (orange) were tested at 10 nM. Migration was scored at 1, 2, 3 and 4 cm from the open end 
of the capillary (SUM is the variation from control for the total number of cells scored for the 4 distances). Data, plotted as 
percentage variation from control ± SEM, derives from the screening of 72 sperm donors. * indicates a significant variation 
from control and ** indicates a significant difference between test solutions (PEBA and HMPBA) (paired t test, p<0.05). 
 
 
Similarly, 10 nM HMPBA has caused more cells to migrate along capillary tube, although the 
positive effect observed for this boronic acid was lower than PEBA for all distances, ranging 
from 29.1±9.7% (3 cm) to 41.3±16.6% (4 cm). Overall, the total number of cells scored along 
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the capillary was on average 61.0±15.6% and 38.6±12.2% higher than control, respectively 
for PEBA and HMPBA. 
 
4.3.3. Effect of PEBA on acrosome reaction 
Further investigation of potential functional effects of PEBA in human sperm included a 
preliminary assessment of its effect on acrosome reaction. As described in section 4.2.4, 
motile spermatozoa were allowed to capacitate and exposed to a range of PEBA 
concentrations (3 nM – 300 µM; Figure 4.4). At concentrations lower than 300 µM, PEBA 
does not seem to cause a significant difference in the incidence of AR, with mean AR 
stimulation across both experiments (see section 4.2.4 for AR stimulation definition) varying 
between -2.2±1.3% for 3 nM PEBA, and 4.3±1.8% for 300 nM PEBA. However, 300 µM PEBA 
did cause a noticeable increase in number of cells undergoing AR, with a mean AR 
stimulation of 7.4±2.1%.  
 
 
 
Figure 4.4 – Effect of PEBA on acrosome reaction 
Acrosome reaction triggered by increasing concentrations of PEBA (3x10
-9
 to 3x10
-4
 M) in mature human sperm. Data 
includes 2 experiments across 2 donors (donor A and donor B). 
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4.3.4. Characterisation of PEBA-evoked Ca2+ signaling 
As part of the characterisation of the Ca2+ signaling events observed when human sperm are 
exposed to PEBA, a series of high speed single-cell Ca2+ imaging experiments was conducted 
aiming to define the subcellular onset of the calcium signaling (Figure 4.5). Briefly, and as 
described in section 4.2.2, motile spermatozoa were isolated and allowed to capacitate for 5 
hours. After labelling with the appropriate calcium indicator (Ca2+ Green-1) cells were kept 
under constant perfusion and exposed to a 20 second application of 10 nM PEBA. [Ca2+]i was 
monitored at 12.5 Hz for 70 seconds from start of PEBA application and raw intensities 
extracted. For each cell analysed two areas of interest (AOIs) were drawn (one including the 
whole head and the other including the whole midpiece) and onset of the calcium signal was 
recorded. The delays observed ranged from -3.44 seconds (negative delay describes a signal 
initiated on the sperm head and propagated to the midpiece 3.44 seconds later) to +3.52 
seconds (positive value describes a signal initiated on the midpiece and 3.52 seconds later 
propagated to the sperm head). Overall, signals tended to start in the midpiece rather than 
the head, with a mean delay across the cell population observed of +0.44±0.38 seconds. 
These differences, however, proved non-significant on a one-sample t test (t(18)=1.154, 
p<0.264). 
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Figure 4.5 – Subcellular onset of Ca
2+
responses triggered by 10 nM PEBA in human spermatozoa 
Boxplot illustrates distribution of the Ca
2+
 response onset delay (s) across sperm head and midpiece. Data includes 19 cells 
and whiskers represent minimum and maximum values.  
 
Further investigations on the PEBA-evoked signal characterisation involved the use of 
inhibitors of key molecules in Ca2+ signal transduction to have an insight over which 
pathways might be involved (Figure 4.6). To this effect, a series of experiments was carried 
out (as described in section 4.2.2) where motile sperm were allowed to capacitate and 
exposed to 10 nM PEBA both in absence and presence of each of the three inhibitors tested 
(25 µM cAMPS-Rp, 5 µM U 73122 and 10 µM NNC 55-0396) whilst [Ca2+]i was being 
monitored. Inhibition (defined as the number of cells that, after responding to application of 
PEBA on its own, fail to respond when PEBA is co-presented with the inhibitor) was highest 
for NNC 55-0396 (73.7±2.0%), closely followed by U 73122 (67.3±6.3%). cAMPS-Rp, however, 
caused a much lower level of inhibition than the other two inhibitors, with only 33.9±10.1% 
of the cells failing to display Ca2+ transients when PEBA was co-applied with the inhibitor. 
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Regarding the results above, however, it is worth noting that, as shown earlier (section 
3.3.7), all the inhibitors tested had themselves more or less dramatic effects in [Ca2+]i (Figure 
3.14).  
 
 
 
Figure 4.6 – Inhibition of calcium signaling events triggered by 10 nM PEBA in human sperm  
Inhibitors tested were: cAMPS-Rp (25 µM), U 73122 (5 µM) and NNC 55-0396 (10 µM). Sperm cells were allowed to 
capacitate for at least 5 hours, labelled with 7.5µM Ca
2+
 Green and exposed to three applications of PEBA alone and one 
application of PEBA + inhibitor. Data, plotted as percentage inhibition ± SEM (see section 3.2.2 for inhibition definition), 
consists of 2 experiments for each inhibitor, each including an average of 290 cells. 
 
 
A final set of experiments was undertaken investigating combined effects on human sperm 
migration when spermatozoa were exposed to both boronic acids tested in section 4.3.2 
(HMPBA and PEBA, both at 10 nM) in conjunction with the inhibitors tested above in this 
section. Boric acid (10 nM BA) was included as an extra test compound, and additionally, 
caffeine (1 mM), as a known stimulant of sperm motility (Lardy et al., 1971), was included as 
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percentage variation from control of the total number of cells scored along the capillary ± 
SEM, show all sperm enhancers causing a positive effect on sperm migration (Figure 4.7 A), 
although none of these variations proved statistically significant in this small dataset when 
compared to control (paired t test, p>0.05). PEBA caused the highest increase in total 
number of cells migrating into the capillary, causing 42.7±19.7% more cells to migrate into 
the capillary, followed by BA, which caused a slightly lower increase of 28.4±19.9%, whereas 
the effect observed for HMPBA and caffeine was less than half of PEBA’s (11.5±13.6 and 
15.2±15.6%, respectively).  
When enhancers were tested in conjunction with 25 µM cAMPS-Rp (cAMP analogue that 
acts as a competitive antagonist of the cAMP-induced activation of PKA), the positive effect 
mentioned above was largely abolished (Figure 4.7 B) for all enhancers tested, with caffeine 
showing the biggest drop (65.5±15.8%) in number of sperm penetrating the capillary, 
followed by BA, with a decrease of 53.7±20.6%. Similar results were obtained for 5 µM U 
73122, albeit slightly less dramatic, with reductions around 35% for the boronic acids and 
slightly higher (53.6±14.5%) for caffeine.  
Under control conditions (no enhancer added to the sperm suspension; Figure 4.7 B – 
Control + Inhibitor), both inhibitors tested showed themselves a detrimental influence on 
sperm migration, with 5 µM U 73122 causing a more dramatic effect in the number of cells 
travelling up the capillary than 25µM cAMPS-Rp (reductions of 58.0±17.2% and 33.2±19.0%, 
respectively), although differences from control were found to be non-significant (paired t 
test, p>0.05). 
116 
 
 
 
Figure 4.7 – Effects of sperm motility enhancers and key pathway inhbitors on sperm migration 
A. Effect of boronic acids (HMPBA, BA and PEBA, all at 10 nM) and caffeine (1 mM) on human sperm migration; B. 
Combined effect of motility / migration enhancers and inhibitors acting on IP3 (5 µM U73122) and cAMP (25 µM cAMPS-Rp) 
pahways on human sperm migration. Data, ploted as variation from control ± SEM, consists of four experiments across four 
different donors. 
 
 
4.4. Discussion 
Ongoing research within our lab has identified a compound (phenethylboronic acid – PEBA) 
apparently capable of enhancing human sperm migration on a test mimicking in vivo cervical 
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mucus penetration (modified Kremer test – Kremer, 1965). The purpose of the work 
discussed below has been both to validate the enhancing capabilities PEBA has previously 
shown over human sperm, but also to attempt to characterise the mechanisms involved in 
possible physiological and functional effects PEBA triggers in sperm. With this in mind, and 
because of calcium’s central role in most cellular events in human sperm (Publicover et al., 
2007), the effect of PEBA on [Ca2+]i was investigated (Figure 4.1). The boronic acid caused 
Ca2+ transients on capacitated human sperm over a range of concentrations, and these 
consistently proved re-evocable on most cells observed, with responses to higher PEBA 
concentrations (10 – 100 nM) displaying, at least first glance, similar kinetics to the traces 
evoked by 3.2 µM progesterone. Because transients were observed for concentrations as 
low as 3 pM, a broader concentration range was tested (Figure 4.2), aiming to define a 
reasonable PEBA concentration to be used in subsequent studies. Unlike what was seen for 
Ω (section 3.3.1), the relation between percentage of cells developing transients and the 
logarithm of the PEBA concentration tested has not resulted in the typical sigmoid dose-
response curve when the non-linear fit was tested. This looks likely to result from the 
chemical being active over a broader concentration range than the one tested, which is in 
itself surprising, as 3 fM PEBA still triggered transients in just under a fourth of the cell 
population (24%). Further testing would have been necessary to draw a more complete and 
explicit dose-response curve, featuring even higher dilutions of the chemical. Nevertheless, 
the current results did provide a good indication to decide on the further testing of PEBA 
within the lower nM range, which proved active in 60-70% of the cells observed.  
To contextualise the Ca2+ signals observed, and test for functional effects these might relate 
to, a large dataset was gathered by testing PEBA, alongside another boronic acid (2-
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(Hydroxymethyl)phenylboronic acid – HMPBA) which also showed promise in enhancing 
sperm migration, in the standard penetration test used in our lab (modified Kremer test – 
see section 4.2.3). The dataset included the screening of 72 sperm donors for the effects of 
both boronic acids on human sperm migration (Figure 4.3). It is worth highlighting that this 
test intends to mimic conditions encountered by freshly ejaculated sperm migrating from 
the vagina, through the cervix and into the uterus: both the distances presented, but 
importantly also the viscosity of the media, are closely related to what sperm would 
encounter in vivo around ovulation. Sperm migration was significantly enhanced when cells 
were exposed to either of the chemicals. Moreover, this enhancement was significantly 
higher for PEBA than for HMPBA, with 61.0±15.6% more cells scored in the microcapillary 
than in control, as opposed to 38.6±12.2% observed for HMPBA. These results strongly 
suggest both chemicals are triggering signaling cascades in sperm that ultimately result in 
one or more behavioural effects responsible by the functional effect observed. These could 
certainly be due to a chemokinetic effect on sperm motility, which would explain the 
increased number of cells migrating into the capillary, but trapping in the capillary by 
increased hyperactivation rates or even a negative chemotactic cannot be ruled out at 
present. Investigation over effects on motility parameters and hyperactivation like the one 
described for Ω (section 3.3.6) will be crucial in providing a more educated answer to this 
question, and will surely be underway in the near future.  
Because a relatively high percentage of cells developed Ca2+ transients in response to PEBA, 
an additional set of experiments was conducted to investigate the effect of this chemical on 
acrosome reaction (Figure 4.4). Although reported as preliminary (dataset consists of two 
observations across two donors), the results indicate that PEBA concentrations below 30 µM 
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do not cause major effects in AR, with AR stimulation sitting below 5%. 300 µM, however, 
caused a relatively higher AR stimulation (7.4±2.1%), which could point to a significant effect 
of the chemical for concentrations in the mM range. A larger dataset would certainly benefit 
any definite conclusions to be taken, but it seems likely that the effect of PEBA in AR is 
negligible, at least for the concentration used in the migration studies (10 nM). At the lowest 
concentration tested (3 nM), the chemical causes a negative AR stimulation (-2.2±1.3%); it 
would be interesting to know if, on an extended dataset, this and lower concentrations 
would maintain the trend, resulting in a measurable reduction on the spontaneous AR rate.  
In order to gain some understanding on the characteristics of the calcium response caused 
by PEBA in capacitated spermatozoa, a preliminary attempt to localise the signal onset was 
undertaken (Figure 4.5), similar to what was done for Ω (see section 3.3.7). Unlike the Ω-
evoked transients, whose signals clearly start in the midpiece before they propagate to the 
head (on average 1.36±0.51 seconds later), onset of PEBA signals could not be significantly 
identified as starting in the midpiece: around two thirds of the cell population observed 
tended to initiate transients in the midpiece, with signal propagating to the sperm head 
0.44±0.38 seconds later. This delay, however, did not prove significantly different from a 
hypothetical zero delay, as shown by a one sample t test (t(18)=1.154, p<0.264). This indicates 
a considerably faster signal propagation between midpiece and head than what was 
previously observed for the Ω response, probably relating to the two chemicals signaling 
through distinct pathways. 
The indication that Ω and PEBA are in fact signaling through different pathways is indeed 
further substantiated by the different inhibition pattern observed for both signals. Where Ω-
response is largely unaffected by exposure to PLC inhibitor U73122 (), interfering with the IP3 
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pathway in the same way causes a much higher inhibition of the PEBA response (Figure 4.6). 
On the other hand, PKA inhibitor cAMPS-Rp, which when tested with Ω resulted in a 
72±14.9% inhibition, has a much lesser effect on the PEBA-evoked response (33.9±10.1% 
inhibition). Interstingly, inhibition levels obtained with NNC 55-0396 are very similar over 
both responses (77.6±3.2% and 73.7±2.0% for Ω and PEBA responses, respectively).  
 
 
 
 
Figure 4.8 – Proposed transduction mechanism for the PEBA-evoked signals in human spermatozoa  
 
 
Although, as discussed in section 3.4, inhibitors tested had themselves significant effects on 
[Ca2+]i, which should not be disregarded, the current results on PEBA signaling point toward 
a bifurcating signal which is highly dependent on both CatSper and PLC, but is still 
considerably affected by PKA blockage. It could be that IP3 and cAMP pathways are both 
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involved in the transduction of the PEBA signal. Such a signal has been described for a 
particular rat OR (rat olfactory receptor I7), whose agonist octanal causes the receptor to 
signal via cAMP at concentrations lower that 10-4 M, but concentrations above that cause 
the receptor to trigger both IP3 and cAMP pathways (Ko and Park, 2006). The model 
proposed in Figure 4.8 intends to summarise how PEBA signal transduction might relate to 
the observed changes in [Ca2+]i. Apart from the involvement of CatSper, PKA and PLC, 
current results provide no solid evidence of the participation of any of the other molecules 
included, but these are known to be present in sperm and are likely to interact in a more or 
less similar manner as described for better studied signalling cascades. As PEBA is shown to 
be signaling mainly via PLC, the possibility of the boronic acid activating a GPCR on the cell’s 
plasma membrane is likely, similarly to what is seen for GPCR activation by certain hormones 
and neurotransmitters in other cell types; however, the possibility of the boronic acid 
stimulating other type of receptor directly or indirectly interacting with PLC cannot be 
discarded. Furthermore, and as recently reviewed by Costello et al., 2009, mammalian sperm 
display all the molecular entities of a functional IP3 signaling pathway, including many of the 
known PLC isoforms (Saunders et al., 2002; Tomes et al., 1996; Walensky et al., 1995), but 
also IP3 receptors (IP3R) (Dragileva et al., 1999; Ho and Suarez, 2001; Ho and Suarez, 2003; 
Kuroda et al., 1999; Naaby-Hansen et al., 2001) and the G-protein alpha subunit (Gαq/11) 
known to activate PLC (Walensky et al., 1995). Ca2+ release from intracellular stores via IP3R 
in the acrosomal membrane and anterior midpiece could explain, at least in part, the rise in 
intracellular calcium levels, and is coherent with the signal’s subcellular onset. On the other 
hand, the involvement of CatSper seems unquestionable, given the level of inhibition 
observed for NNC 55-0396. However, how this channel is being activated is still elusive, as 
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discussed in section 3.4, and direct activation by PEBA remains a possibility. The pathway 
characterisation is therefore still lacking important information and further investigation, in 
particular on the identity of the receptor/s molecule/s involved will be essential in future 
work, but the strong effect of PEBA on sperm motility and the fact that this chemical causes 
functional effects and also Ca2+ responses in human sperm at very low concentrations is 
indicative of a highly sensitive system.  
A final set of experiments was undertaken aiming to investigate if the inhibition effects 
observed on PEBA-evoked Ca2+ signals had a measurable functional effect on sperm 
migration, particularly on the migration enhancement caused by the boronic acid (Figure 
4.7). The migration enhancing effects observed on this subset of experiments for both PEBA 
and HMPBA (Figure 4.7 A) were consistent with what was previously reported (see section 
4.3.2). Additionally, another boronic acid (boric acid - BA) was tested, alongside caffeine, a 
known stimulant of sperm motility (Lardy et al., 1971). As this was a preliminary 
investigation, and the dataset comprised a total of four experiments across four donors, the 
differences in migration were not statistically significant from control for any of the 
enhancers, although previous data gathered for PEBA and HMPBA proved otherwise. In 
terms of effects of the inhibitors tested (Figure 4.7 B), both cAMPS-Rp and U73122 caused a 
substantial reduction on sperm migration themselves: in control cells exposed only to the 
inhibitor, cAMPS-Rp has caused a 33.2±19.0% reduction in the number of cells scored in the 
capillary, whereas U73122 had an even higher detrimental effect (53.6±14.5%). This clearly 
indicates a negative effect on sperm motility, but interpretation of similar results obtained 
for cells exposed to the enhancers in presence of either inhibitor is therefore less 
straightforward, as it isn’t clear if any of the effects observed for the different enhancers 
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have a direct causal link to the enhancer itself or if they represent combined effects of both 
inhibitor and enhancer. Nevertheless, it seems that migration is further reduced when 
enhancers were tested in presence of cAMPS-Rp, whereas in presence of U73122, all boronic 
acids, but not caffeine seem to cause sperm to slightly recover from the detrimental effect 
the inhibitor has on migration.  
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5. GENERAL DISCUSSION 
The data presented has assisted in characterising human olfactory receptor (OR2AE1) 
believed to be prevalent on sperm surface from proteomic evidence (Baker et al., 2007; 
Lefievre et al., 2007). A potent agonist (Ω) was identified for the receptor and its effects as a 
motility and acrosomal status modulating agent, but importantly also as sperm 
chemoattractant were examined. Contrastingly, a novel modulator of sperm motility, 
phenethylboronic acid (PEBA), has also been examined and the second messenger systems 
identified, allowing comparison of the data, though as yet we have no identified receptor for 
this action. 
The agonist identified for OR2AE1 within the heterologous expression system proved 
effective in triggering calcium signals in human sperm, which we believe, are likely to be 
mediated by the native receptor expressed in sperm. These signals were largely abolished by 
the T-type Ca2+ channel inhibitor NNC 55-0396, probably by its action on CatSper, but also by 
blocking mAC activity with SQ22536. The inhibition pattern observed for the Ω response, 
together with the observation that its onset is slower than the one observed for the 
progesterone-mediated signal substantiate that, unlike progesterone-mediated signals, 
reported to result from direct activation of CatSper (Lishko et al., 2011; Strunker et al., 
2011), calcium entry via CatSper or another channel on the Ω-evoked signal is via a second-
messenger activation, likely related to raised levels of cAMP resulting from OR2AE1 
stimulation.  
The inhibition pattern observed for PEBA indicates a different signal transduction pathway to 
that for Ω: the stimulation of a receptor whose identity is not yet known causes activation of 
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PLC, but also seems to relate to PKA activity, whose blockage causes a substantial reduction 
of the response, although not as dramatic as when PLC is inhibited. Similar to the Ω signals, 
most of the calcium influx may be mediated by CatSper as indicated by its NNC 55-0396 
sensitivity.  
Both the heterologous system and sperm showed responses to other molecules in the 
odorant mixtures tested, and similarly, sperm also responded not only to PEBA but also to 
some other boronic acids (though to a much lesser extent), both functionally and via Ca2+ 
transients. If these responses are specific, this could be indicative of a more broadly tuned 
receptor which can be stimulated by closely related molecules, be it because these share the 
same vibrational pattern (according to the vibrational model - Franco et al., 2011) or a 
particular molecular shape (in tune with the “lock-and-key” model). Such a characteristic is 
not unusual amongst ORs, with some receptors being activated by a range of structurally (or 
spectrally) similar odorants instead of showing a strict specificity towards a single molecule 
(Malnic et al., 1999; Mombaerts, 2004; Veitinger et al., 2011). Alternatively, sperm could be 
responding to different stimuli via other receptors yet to be identified.  
Further work on olfactory receptors in sperm would be advanced if specific targeted 
antibodies were available. If time allowed it would be interesting to screen the Ω responses I 
observed with a wider array of inhibitors. This could include trying to find a competing 
volatile, such as undecanal was suggested to be for bourgeonal, though my finding that this 
was not occurring may make such a discovery unlikely. Only when ongoing research into the 
contents of female tract secretions identifies a panel of chemicals that can be tested on the 
ORs are we likely to know the form of the true physiological agonist. 
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In the intracellular calcium imaging experiments performed, the single-wavelength dye 
Calcium Green-1 AM was employed as it has an established history in our research of low 
toxicity to sperm over prolonged imaging periods. A potential disadvantage of this strategy 
versus using alternative ratiometric dyes like Fura-2 AM is that calibration of calcium 
concentrations could not be performed. However, because most of the experiments 
required long exposure sequences, the benefit of the extra data from ratiometric 
measurements did not outweigh the increased cytotoxicity likely to occur due to long 
exposure to UV light.  
The mechanisms behind this complexity are something about which we still have no 
knowledge – both PEBA and Ω induce sperm *Ca2+]i signaling which to the observer is similar, 
yet across dosage ranges and chemicals causes totally different migration phenotypes to be 
displayed. It is clear that a greater understanding of the sperm flagellar beat will be crucial to 
comprehending this (Gaffney et al., 2010) alongside assessment in the correct relative 
viscosity (Kirkman-Brown and Smith, 2011) and higher speed and resolution calcium imaging. 
The calcium signalling in the oocyte and the contribution of the sperm is probably better 
understood now (reviewed in Whitaker, 2006) and whether certain components, such as 
PLCzeta may have a role in both sperm signalling and later in the oocyte is an intriguing 
possibility (Saunders et al., 2002). 
 
It is tempting to speculate that a substantial portion of the people with ‘unexplained 
infertility’ may have functional sperm issues that could be diagnosed with development of 
tests such as those based around effects of motility-modulating agents, but again this would 
mean using the agent in the relevant context to find the result which may add unnecessary 
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complexity to standard semen analysis. One tempting idea being that men could sniff a 
‘smell panel’ which could confirm whether they had functioning olfactory receptors of the 
relevant kind being expressed – as a non-invasive assay.  
In summary, within the current work I was able to functionally express OR2AE1 in HEK293 
cells and used this system to identify a potent agonist (Ω) for the receptor from a library of 
odorant compounds. Testing this agonist in human sperm, where OR2AE1 is known to be 
ectopically expressed, I have shown that 50 µM Ω triggers re-evocable Ca2+ responses in 
capacitated spermatozoa and that the same concentration of agonist acts as a 
chemoattractant. On a parallel approach, I have also tested a related odorant (PEBA) which 
proved capable of triggering calcium signals associated with a significant increase in sperm 
migration. 
Functionally the ability to derive a treatment based upon my data may be some distance 
away, however the ability of PEBA to increase migration of sperm from semen is a useful 
property with a potential that, if harnessed in a vaginal lubricant, could assist natural 
fecundity. 
As knowledge around the agonists and antagonists of these motility systems emerges there 
may be further therapeutic or contraceptive developments that become possible and use of 
sperm motility as a truly affordable way to help people with their fertility problem is an 
inspiring target that I hope to have made incremental progress towards. 
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6. APPENDIX I: MEDIA 
Dulbecco's Modified Eagle Medium (D-MEM) (1X) liquid (high glucose)  
COMPONENTS 
Molecular 
Weight 
Concentration  
(mg/L) mM 
Glycine 75 30 0.4 
L-Arginine hydrochloride 211 84 0.398 
L-Cystine 2HCl 313 63 0.201 
L-Glutamine 146 580 3.97 
L-Histidine hydrochloride-H2O 210 42 0.2 
L-Isoleucine 131 105 0.802 
L-Leucine 131 105 0.802 
L-Lysine hydrochloride 183 146 0.798 
L-Methionine 149 30 0.201 
L-Phenylalanine 165 66 0.4 
L-Serine 105 42 0.4 
L-Threonine 119 95 0.798 
L-Tryptophan 204 16 0.0784 
L-Tyrosine 181 72 0.398 
L-Valine 117 94 0.803 
Choline chloride 140 4 0.0286 
D-Calcium pantothenate 477 4 0.00839 
Folic Acid 441 4 0.00907 
Niacinamide 122 4 0.0328 
Pyridoxine hydrochloride 204 4 0.0196 
Riboflavin 376 0.4 0.00106 
Thiamine hydrochloride 337 4 0.0119 
i-Inositol 180 7.2 0.04 
Calcium Chloride (CaCl2·2H2O) 147 264 1.8 
Ferric Nitrate (Fe(NO3)3·9H2O) 404 0.1 0.000248 
Magnesium Sulfate (MgSO4·7H2O) 246 200 0.813 
Potassium Chloride (KCl) 75 400 5.33 
Sodium Bicarbonate (NaHCO3) 84 3700 44.05 
Sodium Chloride (NaCl) 58 6400 110.34 
Sodium Phosphate monobasic (NaH2PO4·2H2O) 154 141 0.916 
D-Glucose (Dextrose) 180 4500 25 
Phenol Red 376.4 15 0.0399 
Sodium Pyruvate 110 110 1 
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Suplemented Earls Balanced Salt Solution (sEBSS) 
COMPONENTS 
Molecular 
Weight 
Concentration 
(g/L) mM 
Sodium phosphate (NaH2PO4·2H2O) 156.01 0.158 1.01 
Potassium chloride (KCl) 74.55 0.4 5.37 
Magnesium sulphate (MgSO4·7H2O) 246.48 0.2 0.81 
Dextrose (C6H12O6) 180.16 1 5.55 
Sodium pyruvate (C3H3NaO3) 110.05 0.3 2.73 
dl-lactic acid (C3H6O3) 112.06 4.68 41.76 
Calcium chloride (CaCl2·2H2O) 147.02 0.264 1.80 
Sodium bicarbonate (NaHCO3) 84.01 2.2 26.19 
Sodium chloride (NaCl) 58.44 6.8 116.36 
285 <mOsm< 295; 7.15 <pH< 7.45; I (Ionic strength) ~ 0.361; 0.3% BSA added before use for final 
capacitating formulation (sEBSS) 
 
Tyrodes Solution 
140 mM NaCl  
10 mM HEPES 
10mM Glucose 
10 mM Pyruvic acid 
5 mM KCl 
1 mM MgCl2.6H2O 
1 mM CaCl2 
 
pH ~ 7.4 
Osm ~ 300 mOsm 
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7. APPENDIX II: SUPPLEMENTARY DATA 
 
Supp. Figure 1 - Calcium responses to mixtures A and B 
Mixtures include 50 odorants each at 50 µM. HEK293 cells were transfected with 2 µg of plasmid DNA (OR2Y1 or mock) 24 
hours after plating and labelled with 7.5 µM Ca2+ Green-1 24 hours after transfection. Single cell calcium imaging readings 
taken at 2 s intervals and processed data, plotted as percentage of responding cells ± SEM, consists of 7 experiments, each 
including an average of 230 cells; Differences between mean values of receptor and mock transfected cells responding are 
not statistically significant (paired T test, t(6), P > 0.05). 
 
 
Supp. Figure 2 - Total calcium responses to mixtures D to H 
Mixtures include 10 odorants each at 50 µM. HEK293 cells were transfected with 2 µg of plasmid DNA (OR2Y1 or mock) 24 
hours after plating and labelled with 7.5 µM Ca2+ Green-1 24 hours after transfection. Single cell calcium imaging readings 
taken at 2 s intervals and processed data, plotted as percentage of responding cells ± SEM, consists of 7 experiments, each 
including an average of 230 cells; Differences between mean values of receptor and mock transfected cells responding are 
not statistically significant (paired T test, t(6), P > 0.05). 
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Supp. Figure 3 - Effect of Ω on acrosome reaction 
Acrosome reaction triggered by 5, 50 and 500 µM Ω in mature human sperm. Data, plotted as percentage of acrosome 
reacted cells ± SEM, includes 6 experiments across 6 donors.  
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Supp. Figure 4 – Effects of 50 µM Ω on human sperm motility observed by CASA 
For each variable, results represent variation from control ± SEM over one hour (T0 to T60 minutes). 
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Supp. Figure 5 – Kinetics of Ca
2+
 transients evoked by 50 and 500 µM Ω 
Traces (50 µM – green trace; 500 µM – orange trace) represent the average of the normalised fluorescence variations of all 
the cells observed (n=273 cells) in a single experiment where 50 and 500 uM Ω were presented sequentially as 20 second 
applications, intercalated with a 5 minute resting period. 
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